<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">
<html xmlns="http://www.w3.org/1999/xhtml" xml:lang="en" lang="en">
    
    <head><meta http-equiv="Content-Type" content="text/html; charset=utf-8" />
        <!-- AppResources meta begin -->
        <meta name="paf-app-resources" content="" />
                 <script type="text/javascript">var ncbi_startTime = new Date();</script>
            
        <!-- AppResources meta end -->
        
        <!-- TemplateResources meta begin -->
        <meta name="paf_template" content="" />

        <!-- TemplateResources meta end -->
        
        <!-- Logger begin -->
        <meta name="ncbi_db" content="books" /><meta name="ncbi_pdid" content="book-part" /><meta name="ncbi_acc" content="NBK148820" /><meta name="ncbi_domain" content="gene" /><meta name="ncbi_report" content="record" /><meta name="ncbi_type" content="fulltext" /><meta name="ncbi_objectid" content="" /><meta name="ncbi_pcid" content="/NBK148820/" /><meta name="ncbi_pagename" content="EZH2-Related Overgrowth - GeneReviews® - NCBI Bookshelf" /><meta name="ncbi_bookparttype" content="chapter" /><meta name="ncbi_app" content="bookshelf" />
        <!-- Logger end -->
        
        <title>EZH2-Related Overgrowth - GeneReviews® - NCBI Bookshelf</title>
        
        <!-- AppResources external_resources begin -->
        <link rel="stylesheet" href="/core/jig/1.14.8/css/jig.min.css" /><script type="text/javascript" src="/core/jig/1.14.8/js/jig.min.js"></script>

        <!-- AppResources external_resources end -->
        
        <!-- Page meta begin -->
        <meta name="robots" content="INDEX,FOLLOW,NOARCHIVE" /><meta name="citation_inbook_title" content="GeneReviews® [Internet]" /><meta name="citation_title" content="EZH2-Related Overgrowth" /><meta name="citation_publisher" content="University of Washington, Seattle" /><meta name="citation_date" content="2018/08/02" /><meta name="citation_author" content="Katrina Tatton-Brown" /><meta name="citation_author" content="Nazneen Rahman" /><meta name="citation_pmid" content="23865096" /><meta name="citation_fulltext_html_url" content="https://www.ncbi.nlm.nih.gov/books/NBK148820/" /><meta name="citation_keywords" content="EZH2-Related Weaver Syndrome" /><meta name="citation_keywords" content="Histone-lysine N-methyltransferase EZH2" /><meta name="citation_keywords" content="EZH2" /><meta name="citation_keywords" content="EZH2-Related Overgrowth" /><link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /><meta name="DC.Title" content="EZH2-Related Overgrowth" /><meta name="DC.Type" content="Text" /><meta name="DC.Publisher" content="University of Washington, Seattle" /><meta name="DC.Contributor" content="Katrina Tatton-Brown" /><meta name="DC.Contributor" content="Nazneen Rahman" /><meta name="DC.Date" content="2018/08/02" /><meta name="DC.Identifier" content="https://www.ncbi.nlm.nih.gov/books/NBK148820/" /><meta name="description" content="EZH2-related overgrowth includes EZH2-related Weaver syndrome at one end of the spectrum and tall stature at the other. Although most individuals diagnosed with a heterozygous EZH2 pathogenic variant have been identified because of a clinical suspicion of Weaver syndrome, a minority have been identified through molecular genetic testing of family members of probands or individuals with overgrowth who did not have a clinical diagnosis of Weaver syndrome. Thus, the extent of the phenotypic spectrum associated with a heterozygous EZH2 pathogenic variant is not yet known." /><meta name="og:title" content="EZH2-Related Overgrowth" /><meta name="og:type" content="book" /><meta name="og:description" content="EZH2-related overgrowth includes EZH2-related Weaver syndrome at one end of the spectrum and tall stature at the other. Although most individuals diagnosed with a heterozygous EZH2 pathogenic variant have been identified because of a clinical suspicion of Weaver syndrome, a minority have been identified through molecular genetic testing of family members of probands or individuals with overgrowth who did not have a clinical diagnosis of Weaver syndrome. Thus, the extent of the phenotypic spectrum associated with a heterozygous EZH2 pathogenic variant is not yet known." /><meta name="og:url" content="https://www.ncbi.nlm.nih.gov/books/NBK148820/" /><meta name="og:site_name" content="NCBI Bookshelf" /><meta name="og:image" content="https://www.ncbi.nlm.nih.gov/corehtml/pmc/pmcgifs/bookshelf/thumbs/th-gene-lrg.png" /><meta name="twitter:card" content="summary" /><meta name="twitter:site" content="@ncbibooks" /><meta name="bk-non-canon-loc" content="/books/n/gene/weaver/" /><link rel="canonical" href="https://www.ncbi.nlm.nih.gov/books/NBK148820/" /><link rel="stylesheet" href="/corehtml/pmc/css/figpopup.css" type="text/css" media="screen" /><link rel="stylesheet" href="/corehtml/pmc/css/bookshelf/2.22/css/books.min.css" type="text/css" /><link rel="stylesheet" href="/corehtml/pmc/css/bookshelf/2.22/css/books_print.min.css" type="text/css" media="print" /><style type="text/css">p a.figpopup{display:inline !important} .bk_tt {font-family: monospace}  .first-line-outdent .bk_ref {display: inline}  .body-content h2, .body-content .h2  {border-bottom: 1px solid #97B0C8} .body-content h2.inline {border-bottom: none} a.page-toc-label , .jig-ncbismoothscroll a {text-decoration:none;border:0 !important} .temp-labeled-list  .graphic {display:inline-block !important} .temp-labeled-list  img{width:100%}</style><script type="text/javascript" src="/corehtml/pmc/js/jquery.hoverIntent.min.js"> </script><script type="text/javascript" src="/corehtml/pmc/js/common.min.js"> </script><script type="text/javascript" src="/corehtml/pmc/js/large-obj-scrollbars.min.js"> </script><script type="text/javascript">window.name="mainwindow";</script><script type="text/javascript" src="/corehtml/pmc/js/bookshelf/2.22/book-toc.min.js"> </script><script type="text/javascript" src="/corehtml/pmc/js/bookshelf/2.22/books.min.js"> </script><meta name="book-collection" content="NONE" />

        <!-- Page meta end -->
    <link rel="shortcut icon" href="//www.ncbi.nlm.nih.gov/favicon.ico" /><meta name="ncbi_phid" content="CE8C0187E0405DF10000000003D10142.m_12" />
<meta name='referrer' content='origin-when-cross-origin'/><link type="text/css" rel="stylesheet" href="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/css/3852956/3985586/3808861/4121862/3974050/3917732/251717/4098876/14534/45193/4113719/3849091/3984811/3751656/4033350/3840896/3577051/3852958/4008682/3881636/3579733/4062871/12930/3964959/3854974/36029/4128070/9685/3549676/3609192/3609193/3609213/3395586.css" /><link type="text/css" rel="stylesheet" href="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/css/3411343/3882866.css" media="print" /></head>
    <body class="book-part">
        <div class="grid">
            <div class="col twelve_col nomargin shadow">
                <!-- System messages like service outage or JS required; this is handled by the TemplateResources portlet -->
                <div class="sysmessages">
                    <noscript>
	<p class="nojs">
	<strong>Warning:</strong>
	The NCBI web site requires JavaScript to function. 
	<a href="/guide/browsers/#enablejs" title="Learn how to enable JavaScript" target="_blank">more...</a>
	</p>
	</noscript>
                </div>
                <!--/.sysmessage-->
                <div class="wrap">
                    <div class="page">
                        <div class="top">
                            <div class="universal_header" id="universal_header"><ul class="inline_list jig-ncbimenu ui-ncbimenu resources_list" id="navcontent"><li class="ui-ncbimenu-item-leaf ui-ncbimenu-item-first ui-helper-reset ui-ncbimenu-item-no-hlt"><a class="ui-ncbimenu-link-first" href="/" role="banner" title="NCBI Home" id="ncbihome" accesskey="1"><span class="offscreen_noflow">NCBI</span><img src="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/img/28977" class="ncbi_logo" title="NCBI" alt="NCBI Logo" /></a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="#maincontent" title="Skip to the content" tabindex="0" accesskey="3">Skip to main
                        content</a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="#navcontent" title="Skip to the navigation" tabindex="0" accesskey="4">Skip to
                        navigation</a></li><li id="resource-menu" class="topmenu ui-helper-reset ui-ncbimenu-item-first ui-helper-reset"><a class="ui-ncbimenu-first-link-has-submenu ui-ncbimenu-link-first topanchor expandDown" href="/static/header_footer_ajax/submenu/#resources">Resources</a></li><li id="all-howtos-menu" class="topmenu ui-helper-reset ui-ncbimenu-item-first"><a class="ui-ncbimenu-first-link-has-submenu ui-ncbimenu-link-first topanchor expandDown" href="/static/header_footer_ajax/submenu/#howto">How To</a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="/guide/browsers/#accesskeys" title="About My NCBI Accesskeys" tabindex="0" accesskey="0">About NCBI Accesskeys</a></li></ul><div class="myncbi"><span id="myncbiusername" style="display:none"><a href="/account/settings/" id="mnu" title="Edit account settings"></a></span><a accesskey="2" href="/myncbi/" id="myncbi" style="display:none">My NCBI</a><a href="/account/" id="sign_in">Sign in to NCBI</a><a href="/account/signout/" id="sign_out" style="display:none">Sign Out</a></div></div>
                            <div class="header">
    <div class="res_logo"><h1 class="res_name"><a href="/books/" title="Bookshelf home">Bookshelf</a></h1><h2 class="res_tagline"></h2></div>
    <div class="search"><form method="get" action="/books/"><div class="search_form"><label for="database" class="offscreen_noflow">Search database</label><select id="database"><optgroup label="Recent"><option value="books" selected="selected" class="last" data-ac_dict="bookshelf-search">Books</option></optgroup><optgroup label="All"><option value="gquery">All Databases</option><option value="assembly">Assembly</option><option value="biocollections">Biocollections</option><option value="bioproject">BioProject</option><option value="biosample">BioSample</option><option value="biosystems">BioSystems</option><option value="books" data-ac_dict="bookshelf-search">Books</option><option value="clinvar">ClinVar</option><option value="cdd">Conserved Domains</option><option value="gap">dbGaP</option><option value="dbvar">dbVar</option><option value="gene">Gene</option><option value="genome">Genome</option><option value="gds">GEO DataSets</option><option value="geoprofiles">GEO Profiles</option><option value="gtr">GTR</option><option value="homologene">HomoloGene</option><option value="ipg">Identical Protein Groups</option><option value="medgen">MedGen</option><option value="mesh">MeSH</option><option value="ncbisearch">NCBI Web Site</option><option value="nlmcatalog">NLM Catalog</option><option value="nuccore">Nucleotide</option><option value="omim">OMIM</option><option value="pmc">PMC</option><option value="popset">PopSet</option><option value="probe">Probe</option><option value="protein">Protein</option><option value="proteinclusters">Protein Clusters</option><option value="pcassay">PubChem BioAssay</option><option value="pccompound">PubChem Compound</option><option value="pcsubstance">PubChem Substance</option><option value="pubmed">PubMed</option><option value="snp">SNP</option><option value="sparcle">Sparcle</option><option value="sra">SRA</option><option value="structure">Structure</option><option value="taxonomy">Taxonomy</option><option value="toolkit">ToolKit</option><option value="toolkitall">ToolKitAll</option><option value="toolkitbookgh">ToolKitBookgh</option></optgroup></select><div class="nowrap"><label for="term" class="offscreen_noflow" accesskey="/">Search term</label><div class="nowrap"><input type="text" name="term" id="term" title="Search Books. Use up and down arrows to choose an item from the autocomplete." value="" class="jig-ncbiclearbutton jig-ncbiautocomplete" data-jigconfig="dictionary:'bookshelf-search',disableUrl:'NcbiSearchBarAutoComplCtrl'" autocomplete="off" data-sbconfig="ds:'no',pjs:'no',afs:'no'" /></div><button id="search" type="submit" class="button_search nowrap" cmd="go">Search</button></div></div></form><ul class="searchlinks inline_list"><li>
                        <a href="/books/browse/">Browse Titles</a>
                    </li><li>
                        <a href="/books/advanced/">Advanced</a>
                    </li><li class="help">
                        <a href="/books/NBK3833/">Help</a>
                    </li></ul></div>
</div>

                            
                            
                        <!--<component id="Page" label="headcontent"/>-->
                            
                        </div>
                        <div class="content">
                            <!-- site messages -->
                            <!-- Custom content 1 -->
<div class="col1">
    
</div>

<div class="container">
    <div id="maincontent" class="content eight_col col">
        <!-- Custom content in the left column above book nav -->
        <div class="col2">
            
        </div>
        
        <!-- Book content -->
        

        <!-- Custom content between navigation and content -->
        <div class="col3">
            
        </div>
        
        <div class="document">
            <div class="pre-content"><div><div class="bk_prnt"><p class="small">NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.</p><p>Adam MP, Ardinger HH, Pagon RA, et al., editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2019. </p></div><div class="iconblock clearfix whole_rhythm no_top_margin bk_noprnt"><a class="img_link icnblk_img" title="All GeneReviews" href="/books/n/gene/"><img class="source-thumb" src="/corehtml/pmc/pmcgifs/bookshelf/thumbs/th-gene-lrg.png" alt="Cover of GeneReviews®" height="100px" width="80px" /></a><div class="icnblk_cntnt eight_col"><h2>GeneReviews<sup>®</sup> [Internet].</h2><a data-jig="ncbitoggler" href="#__NBK148820_dtls__">Show details</a><div style="display:none" class="ui-widget" id="__NBK148820_dtls__"><div>Adam MP, Ardinger HH, Pagon RA, et al., editors.</div><div>Seattle (WA): <a href="http://www.washington.edu" ref="pagearea=page-banner&amp;targetsite=external&amp;targetcat=link&amp;targettype=publisher">University of Washington, Seattle</a>; 1993-2019.</div></div><div class="half_rhythm"><ul class="inline_list"><li style="margin-right:1em"><a class="bk_cntns" href="/books/n/gene/">GeneReviews by Title</a></li></ul></div><div class="bk_noprnt"><form method="get" action="/books/n/gene/" id="bk_srch"><div class="bk_search"><label for="bk_term" class="offscreen_noflow">Search term</label><input type="text" title="Search GeneReviews" id="bk_term" name="term" value="" data-jig="ncbiclearbutton" /> <input type="submit" class="jig-ncbibutton" value="Search GeneReviews" submit="false" style="padding: 0.1em 0.4em;" /></div></form><div><ul class="inline_list"><li><a href="/books/n/gene/advanced/">GeneReviews Advanced Search</a></li><li style="margin-left:.5em"><a href="/books/n/gene/helpadvsearch/">Help</a></li></ul></div></div></div><div class="icnblk_cntnt two_col"><div class="pagination bk_noprnt"><a class="active page_link prev" href="/books/n/gene/exosc3-pc-hypo-p/" title="Previous page in this title">&lt; Prev</a><a class="active page_link next" href="/books/n/gene/alzheimer-early/" title="Next page in this title">Next &gt;</a></div></div></div></div></div>
            <div class="main-content lit-style" itemscope="itemscope" itemtype="http://schema.org/CreativeWork"><div class="meta-content fm-sec"><h1 id="_NBK148820_"><span class="title" itemprop="name"><i>EZH2</i>-Related Overgrowth</span></h1><p class="contrib-group"><span itemprop="author">Katrina Tatton-Brown</span>, BM BCh, MD and <span itemprop="author">Nazneen Rahman</span>, BM BCh, PhD.</p><a data-jig="ncbitoggler" href="#__NBK148820_ai__" style="border:0;text-decoration:none">Author Information</a><div style="display:none" class="ui-widget" id="__NBK148820_ai__"><div class="contrib half_rhythm"><span itemprop="author">Katrina Tatton-Brown</span>, BM BCh, MD<div class="affiliation small">Consultant and Honorary Reader in Clinical Genetics<br />St George's University of London<br />St George's University Hospital NHS Foundation Trust<br />London, United Kingdom<div><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="ku.ca.lugs@nottatk" class="oemail">ku.ca.lugs@nottatk</a></div></div></div><div class="contrib half_rhythm"><span itemprop="author">Nazneen Rahman</span>, BM BCh, PhD<div class="affiliation small">Professor of Human Genetics<br />Institute of Cancer Research<br />Sutton, Surrey, United Kingdom</div></div></div><p class="small">Initial Posting: <span itemprop="datePublished">July 18, 2013</span>; Last Update: <span itemprop="dateModified">August 2, 2018</span>.</p><p><em>Estimated reading time: 23 minutes</em></p></div><div class="jig-ncbiinpagenav body-content whole_rhythm" data-jigconfig="allHeadingLevels: ['h2'],smoothScroll: false" itemprop="text"><div id="weaver.Summary" itemprop="description"><h2 id="_weaver_Summary_">Summary</h2><div><h4 class="inline">Clinical characteristics.</h4><p><i>EZH2-</i>related overgrowth includes <i>EZH2-</i>related Weaver syndrome at one end of the spectrum and tall stature at the other. Although most individuals diagnosed with a <a class="def" href="/books/n/gene/glossary/def-item/heterozygous/">heterozygous</a> <i>EZH2</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> have been identified because of a clinical suspicion of Weaver syndrome, a minority have been identified through <a class="def" href="/books/n/gene/glossary/def-item/molecular-genetic-testing/">molecular genetic testing</a> of family members of probands or individuals with overgrowth who did not have a clinical diagnosis of Weaver syndrome. Thus, the extent of the phenotypic spectrum associated with a heterozygous <i>EZH2</i> pathogenic variant is not yet known.</p><p>Weaver syndrome is characterized by tall stature, variable intellect (ranging from normal intellect to severe intellectual disability), characteristic facial appearance, and a range of associated clinical features including advanced bone age, poor coordination, soft doughy skin, camptodactyly of the fingers and/or toes, umbilical hernia, abnormal tone, and hoarse low cry in infancy. Brain MRI has identified abnormalities in a few individuals with <i>EZH2-</i>related overgrowth. Neuroblastoma occurs at a slightly increased frequency in individuals with a <a class="def" href="/books/n/gene/glossary/def-item/heterozygous/">heterozygous</a> <i>EZH2</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> but data are insufficient to determine absolute risk. There is currently no evidence that additional malignancies (including hematologic malignancies) occur with increased frequency.</p></div><div><h4 class="inline">Diagnosis/testing.</h4><p>The diagnosis of <i>EZH2-</i>related overgrowth is based on detection of a <a class="def" href="/books/n/gene/glossary/def-item/heterozygous/">heterozygous</a> <a class="def" href="/books/n/gene/glossary/def-item/germline/">germline</a> <i>EZH2</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> on <a class="def" href="/books/n/gene/glossary/def-item/molecular-genetic-testing/">molecular genetic testing</a><i>.</i></p></div><div><h4 class="inline">Management.</h4><p><i>Treatment of manifestations:</i> For individuals with developmental delay and/or learning disability, referral for learning/behavior/speech assessment and support may be indicated. Occasionally, toe camptodactyly may require surgical release. Physiotherapy may be of benefit to those experiencing joint pain secondary to ligamentous laxity or joint contractures. Treatment of scoliosis is routine. The appropriate specialist referral(s) should be made for other clinical issues.</p><p><i>Surveillance:</i> Regular medical follow up of young children with <i>EZH2-</i>related Weaver syndrome to monitor developmental progress, camptodactyly (for resolution/improvement), and/or hypotonia; medical follow up of older children/teenagers who do not have medical complications may be less frequent. If scoliosis is present, monitoring as per the recommendations of an orthopedist. Although current data do not support specific tumor surveillance programs, clinicians should have a low threshold for investigating any findings that may be tumor (particularly neuroblastoma) related.</p><p><i>Pregnancy management:</i> Families and their health care providers should be aware that an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> baby may be large so that appropriate delivery plans can be made.</p></div><div><h4 class="inline">Genetic counseling.</h4><p><i>EZH2-</i>related overgrowth is inherited in an <a class="def" href="/books/n/gene/glossary/def-item/autosomal-dominant/">autosomal dominant</a> manner; however, many <a class="def" href="/books/n/gene/glossary/def-item/germline/">germline</a> pathogenic <i>EZH2</i> variants arise <a class="def" href="/books/n/gene/glossary/def-item/de-novo/"><i>de novo</i></a>. Each child of an individual with an <i>EZH2</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> has a 50% chance of inheriting the pathogenic variant; the severity of the <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a> in an individual inheriting the <i>EZH2</i> pathogenic variant cannot be predicted. If the pathogenic variant has been identified in an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> family member, <a class="def" href="/books/n/gene/glossary/def-item/prenatal-diagnosis/">prenatal diagnosis</a> for a pregnancy at increased risk and <a class="def" href="/books/n/gene/glossary/def-item/preimplantation-genetic-diagnosis/">preimplantation genetic diagnosis</a> are possible.</p></div></div><div id="weaver.GeneReview_Scope"><h2 id="_weaver_GeneReview_Scope_"><i>GeneReview</i> Scope</h2><div id="weaver.Tc" class="table"><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK148820/table/weaver.Tc/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__weaver.Tc_lrgtbl__"><table class="no_bottom_margin"><thead><tr><th id="hd_h_weaver.Tc_1_1_1_1" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>EZH2</i>-Related Overgrowth: Included Phenotypes</th></tr></thead><tbody><tr><td headers="hd_h_weaver.Tc_1_1_1_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><ul><li class="half_rhythm"><div><i>EZH2</i>-related Weaver syndrome&#x000a0;<sup>1</sup></div></li></ul>
</td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt></dt><dd><div><p class="no_margin">For synonyms and outdated names see <a href="#weaver.Nomenclature">Nomenclature</a>.</p></div></dd><dt>1. </dt><dd><div id="weaver.TF.c.1"><p class="no_margin">For other genetic causes of this <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a> see <a href="#weaver.Differential_Diagnosis">Differential Diagnosis</a>.</p></div></dd></dl></div></div></div></div><div id="weaver.Diagnosis"><h2 id="_weaver_Diagnosis_">Diagnosis</h2><div id="weaver.Suggestive_Findings"><h3>Suggestive Findings</h3><p><i>EZH2</i>-related overgrowth <b>should be suspected</b> in an individual with combinations of the following clinical and imaging findings [<a class="bk_pop" href="#weaver.REF.tattonbrown.2013.2972">Tatton-Brown et al 2013</a>]:</p><p><b>Clinical findings</b></p><ul><li class="half_rhythm"><div class="half_rhythm">Tall stature (height &#x02265;+2 SD)</div></li><li class="half_rhythm"><div class="half_rhythm">Macrocephaly (head circumference &#x02265;+2 SD)</div></li><li class="half_rhythm"><div class="half_rhythm">Intellectual disability</div></li><li class="half_rhythm"><div class="half_rhythm">Characteristic facial appearance</div><ul><li class="half_rhythm"><div>In children younger than age three years: retrognathia, large and fleshy ears, and a "stuck on" appearance to the chin associated with a horizontal skin crease and sometimes a central dimple</div></li><li class="half_rhythm"><div>In <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals of all ages, additional features including (<a class="figpopup" href="/books/NBK148820/figure/weaver.F1/?report=objectonly" target="object" rid-figpopup="figweaverF1" rid-ob="figobweaverF1">Figure 1</a>):</div><ul><li class="half_rhythm"><div>Broad forehead</div></li><li class="half_rhythm"><div>Widely spaced eyes</div></li><li class="half_rhythm"><div>Almond-shaped palpebral fissures</div></li></ul></li></ul><div class="half_rhythm">Note: The characteristic facial appearance (which is most distinctive at a younger age) evolves over time; therefore, review of younger-childhood photographs may help the clinician reach a clinical diagnosis.</div></li><li class="half_rhythm"><div class="half_rhythm">Poor coordination</div></li><li class="half_rhythm"><div class="half_rhythm">Soft and doughy skin</div></li><li class="half_rhythm"><div class="half_rhythm">Camptodactyly of the fingers and/or toes (see <b>Note</b>)</div></li><li class="half_rhythm"><div class="half_rhythm">Umbilical hernia that is occasionally significant enough to require surgical reduction</div></li><li class="half_rhythm"><div class="half_rhythm">Abnormal tone (central hypotonia and/or peripheral hypertonia) (see <b>Note</b>)</div></li><li class="half_rhythm"><div class="half_rhythm">Hoarse, low-pitched cry (sometimes described as a quiet cry)</div></li></ul><div class="iconblock whole_rhythm clearfix ten_col fig" id="figweaverF1" co-legend-rid="figlgndweaverF1"><a href="/books/NBK148820/figure/weaver.F1/?report=objectonly" target="object" title="Figure 1. " class="img_link icnblk_img figpopup" rid-figpopup="figweaverF1" rid-ob="figobweaverF1"><img class="small-thumb" src="/books/NBK148820/bin/weaver-Image001.gif" src-large="/books/NBK148820/bin/weaver-Image001.jpg" alt="Figure 1. . Retrognathia present in younger children with EZH2-related Weaver syndrome usually resolves with age." /></a><div class="icnblk_cntnt" id="figlgndweaverF1"><h4 id="weaver.F1"><a href="/books/NBK148820/figure/weaver.F1/?report=objectonly" target="object" rid-ob="figobweaverF1">Figure 1. </a></h4><p class="float-caption no_bottom_margin">Retrognathia present in younger children with <i>EZH2</i>-related Weaver syndrome usually resolves with age. In individuals of all ages the palpebral fissures are frequently almond-shaped and the eyes are widely spaced. </p></div></div><p><b>Note:</b> A detailed medical history may be necessary to determine if these findings were present in the newborn period / infancy given that they can resolve/improve throughout childhood.</p><p><b>Imaging findings.</b> Advanced bone age on plain radiographs</p><p><b>Brain MRI.</b> In many individuals a brain MRI has not been undertaken and thus imaging data are not available. One or more abnormalities identified in ten individuals included: <a class="def" href="/books/n/gene/glossary/def-item/isolated/">isolated</a> ventriculomegaly ( in 5); ventriculomegaly and periventricular leukomalacia (1); periventricular leukomalacia (1); cerebellar infarct (1); and cerebellar hypoplasia and neuronal migration defects (polymicrogyria) with and without pachygyria (2) [<a class="bk_pop" href="#weaver.REF.alsalem.2013.225">Al-Salem et al 2013</a>, <a class="bk_pop" href="#weaver.REF.tattonbrown.2013.2972">Tatton-Brown et al 2013</a>].</p></div><div id="weaver.Establishing_the_Diagnosis"><h3>Establishing the Diagnosis</h3><p>The diagnosis of <i>EZH2-</i>related overgrowth <b>is established</b> in a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> by identification of a <a class="def" href="/books/n/gene/glossary/def-item/heterozygous/">heterozygous</a> <a class="def" href="/books/n/gene/glossary/def-item/germline/">germline</a> <i>EZH2</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> on <a class="def" href="/books/n/gene/glossary/def-item/molecular-genetic-testing/">molecular genetic testing</a> (see <a class="figpopup" href="/books/NBK148820/table/weaver.T.molecular_genetic_testing_used/?report=objectonly" target="object" rid-figpopup="figweaverTmoleculargenetictestingused" rid-ob="figobweaverTmoleculargenetictestingused">Table 1</a>)<i>.</i></p><p>Molecular genetic testing approaches can include a combination of <b>single-<a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> testing</b>, <b><a class="def" href="/books/n/gene/glossary/def-item/multigene-panel/">multigene panel</a></b>
<b>testing</b>, and <b>comprehensive</b>
<b><a class="def" href="/books/n/gene/glossary/def-item/genomic/">genomic</a> testing</b> (<a class="def" href="/books/n/gene/glossary/def-item/exome-sequencing/">exome sequencing</a>, <a class="def" href="/books/n/gene/glossary/def-item/exome-array/">exome array</a>, <a class="def" href="/books/n/gene/glossary/def-item/genome-sequencing/">genome sequencing</a>):</p><ul><li class="half_rhythm"><div class="half_rhythm"><b>Single-<a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> testing.</b> Single-gene testing requires that the clinician recognize the Weaver syndrome / <i>EZH2</i>-related overgrowth <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a> and request <i>EZH2</i> <a class="def" href="/books/n/gene/glossary/def-item/molecular-genetic-testing/">molecular genetic testing</a><i>.</i> However, given that the phenotype is broad and the facial gestalt subtle, this can be challenging even for the experienced dysmorphologist.</div><div class="half_rhythm">Sequence analysis of <i>EZH2</i> detects small intragenic deletions/insertions and <a class="def" href="/books/n/gene/glossary/def-item/missense/">missense</a>, <a class="def" href="/books/n/gene/glossary/def-item/nonsense-variant/">nonsense</a>, and <a class="def" href="/books/n/gene/glossary/def-item/splice-site/">splice site</a> variants; typically, <a class="def" href="/books/n/gene/glossary/def-item/exon/">exon</a> or whole-<a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> deletions/duplications are not detected. If <a class="def" href="/books/n/gene/glossary/def-item/sequence-analysis/">sequence analysis</a> does not identify a <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>, targeted <a class="def" href="/books/n/gene/glossary/def-item/deletion-duplication-analysis/">deletion/duplication analysis</a> to detect intragenic deletions or duplications can be considered. Note: Whole- or partial-gene deletions have been reported in several individuals with increased growth possibly due to Weaver syndrome [<a class="bk_pop" href="#weaver.REF.imagawa.2017.637">Imagawa et al 2017</a>, <a class="bk_pop" href="#weaver.REF.suri.2017.2731">Suri &#x00026; Dixit 2017</a>].</div></li><li class="half_rhythm"><div class="half_rhythm"><b>Multigene panel testing.</b> More frequently, an individual with <i>EZH2</i>-related overgrowth is diagnosed following testing with a <a class="def" href="/books/n/gene/glossary/def-item/multigene-panel/">multigene panel</a> for conditions characterized by increased growth (height and/or head circumference) in association with intellectual disability (see <a href="#weaver.Differential_Diagnosis">Differential Diagnosis</a>). <i>EZH2</i> is frequently included in such multigene panels. Such a panel is most likely to identify the genetic cause of the condition at the most reasonable cost while limiting identification of variants of <a class="def" href="/books/n/gene/glossary/def-item/uncertain-significance/">uncertain significance</a> and pathogenic variants in genes that do not explain the underlying <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a>.</div><div class="half_rhythm">Note: (1) The genes included in the panel and the diagnostic <a class="def" href="/books/n/gene/glossary/def-item/sensitivity/">sensitivity</a> of the testing used for each <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> vary by laboratory and are likely to change over time. (2) Some multigene panels may include genes not associated with the condition discussed in this <i>GeneReview</i>. (3) In some laboratories, panel options may include a custom laboratory-designed panel and/or custom <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a>-focused <a class="def" href="/books/n/gene/glossary/def-item/exome/">exome</a> analysis that includes genes specified by the clinician. (4) Methods used in a panel may include <a class="def" href="/books/n/gene/glossary/def-item/sequence-analysis/">sequence analysis</a>, <a class="def" href="/books/n/gene/glossary/def-item/deletion-duplication-analysis/">deletion/duplication analysis</a>, and/or other non-sequencing-based tests.</div><div class="half_rhythm">For an introduction to multigene panels click <a href="/books/n/gene/app5/#app5.Multigene_Panels">here</a>. More detailed information for clinicians ordering genetic tests can be found <a href="/books/n/gene/app5/#app5.Multigene_Panels_FAQs">here</a>.</div></li><li class="half_rhythm"><div class="half_rhythm"><b>Comprehensive <a class="def" href="/books/n/gene/glossary/def-item/genomic/">genomic</a> testing.</b> Comprehensive genomic testing allows the sequencing of many genes, often with unrelated phenotypes, in a single experiment. This has particular clinical utility when the clinician does not recognize a particular <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a> and/or genes involved. <b>Exome sequencing</b> is most commonly used; <b><a class="def" href="/books/n/gene/glossary/def-item/genome-sequencing/">genome sequencing</a></b> is also possible. <b>Exome array</b> (when clinically available) may be considered if <a class="def" href="/books/n/gene/glossary/def-item/exome-sequencing/">exome sequencing</a> is not diagnostic.</div><div class="half_rhythm">For an introduction to comprehensive <a class="def" href="/books/n/gene/glossary/def-item/genomic/">genomic</a> testing click <a href="/books/n/gene/app5/#app5.Comprehensive_Genomic_Testing">here</a>. More detailed information for clinicians ordering genomic testing can be found <a href="/books/n/gene/app5/#app5.Comprehensive_Genomic_Testing_1">here</a>.</div></li></ul><div id="weaver.T.molecular_genetic_testing_used" class="table"><h3><span class="label">Table 1. </span></h3><div class="caption"><p>Molecular Genetic Testing Used in <i>EZH2-</i>Related Overgrowth</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK148820/table/weaver.T.molecular_genetic_testing_used/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__weaver.T.molecular_genetic_testing_used_lrgtbl__"><table class="no_bottom_margin"><thead><tr><th id="hd_h_weaver.T.molecular_genetic_testing_used_1_1_1_1" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Gene&#x000a0;<sup>1</sup></th><th id="hd_h_weaver.T.molecular_genetic_testing_used_1_1_1_2" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Method</th><th id="hd_h_weaver.T.molecular_genetic_testing_used_1_1_1_3" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Proportion of Probands with a Pathogenic Variant&#x000a0;<sup>2</sup> Detectable by Method</th></tr></thead><tbody><tr><td headers="hd_h_weaver.T.molecular_genetic_testing_used_1_1_1_1" rowspan="2" scope="row" colspan="1" style="text-align:left;vertical-align:middle;"><i>EZH2</i></td><td headers="hd_h_weaver.T.molecular_genetic_testing_used_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Sequence analysis&#x000a0;<sup>3</sup></td><td headers="hd_h_weaver.T.molecular_genetic_testing_used_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Majority of variants reported to date&#x000a0;<sup>4</sup></td></tr><tr><td headers="hd_h_weaver.T.molecular_genetic_testing_used_1_1_1_2" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">Gene-targeted <a class="def" href="/books/n/gene/glossary/def-item/deletion-duplication-analysis/">deletion/duplication analysis</a>&#x000a0;<sup>5</sup></td><td headers="hd_h_weaver.T.molecular_genetic_testing_used_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">See footnote 6</td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt>1. </dt><dd><div id="weaver.TF.1.1"><p class="no_margin">See <a href="/books/NBK148820/#weaver.molgen.TA">Table A. Genes and Databases</a> for <a class="def" href="/books/n/gene/glossary/def-item/chromosome/">chromosome</a> <a class="def" href="/books/n/gene/glossary/def-item/locus/">locus</a> and protein.</p></div></dd><dt>2. </dt><dd><div id="weaver.TF.1.2"><p class="no_margin">See <a href="#weaver.Molecular_Genetics">Molecular Genetics</a> for information on allelic variants detected in this <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a>.</p></div></dd><dt>3. </dt><dd><div id="weaver.TF.1.3"><p class="no_margin">Sequence analysis detects variants that are benign, likely benign, of <a class="def" href="/books/n/gene/glossary/def-item/uncertain-significance/">uncertain significance</a>, likely pathogenic, or pathogenic. Pathogenic variants may include small intragenic deletions/insertions and <a class="def" href="/books/n/gene/glossary/def-item/missense/">missense</a>, <a class="def" href="/books/n/gene/glossary/def-item/nonsense-variant/">nonsense</a>, and <a class="def" href="/books/n/gene/glossary/def-item/splice-site/">splice site</a> variants; typically, <a class="def" href="/books/n/gene/glossary/def-item/exon/">exon</a> or whole-<a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> deletions/duplications are not detected. For issues to consider in interpretation of <a class="def" href="/books/n/gene/glossary/def-item/sequence-analysis/">sequence analysis</a> results, click <a href="/books/n/gene/app2/">here</a>.</p></div></dd><dt>4. </dt><dd><div id="weaver.TF.1.4"><p class="no_margin">54 individuals with an <i>EZH2</i> <a class="def" href="/books/n/gene/glossary/def-item/germline/">germline</a> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> have been reported [<a class="bk_pop" href="#weaver.REF.tattonbrown.2011.1127">Tatton-Brown et al 2011</a>, <a class="bk_pop" href="#weaver.REF.gibson.2012.110">Gibson et al 2012</a>, <a class="bk_pop" href="#weaver.REF.alsalem.2013.225">Al-Salem et al 2013</a>, <a class="bk_pop" href="#weaver.REF.tattonbrown.2013.2972">Tatton-Brown et al 2013</a>, <a class="bk_pop" href="#weaver.REF.usemann.2016.1274">Usemann et al 2016</a>, <a class="bk_pop" href="#weaver.REF.lui.2018.1470">Lui et al 2018</a>].</p></div></dd><dt>5. </dt><dd><div id="weaver.TF.1.5"><p class="no_margin">Gene-targeted <a class="def" href="/books/n/gene/glossary/def-item/deletion-duplication-analysis/">deletion/duplication analysis</a> detects intragenic deletions or duplications. Methods used may include <a class="def" href="/books/n/gene/glossary/def-item/quantitative-pcr/">quantitative PCR</a>, long-range PCR, multiplex ligation-dependent probe amplification (MLPA), and a <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a>-targeted microarray designed to detect single-<a class="def" href="/books/n/gene/glossary/def-item/exon/">exon</a> deletions or duplications.</p></div></dd><dt>6. </dt><dd><div id="weaver.TF.1.6"><p class="no_margin">Two individuals have had deletions wholly or partially encompassing <i>EZH2</i> [<a class="bk_pop" href="#weaver.REF.imagawa.2017.637">Imagawa et al 2017</a>, <a class="bk_pop" href="#weaver.REF.suri.2017.2731">Suri &#x00026; Dixit 2017</a>].</p></div></dd></dl></div></div></div></div></div><div id="weaver.Clinical_Characteristics"><h2 id="_weaver_Clinical_Characteristics_">Clinical Characteristics</h2><div id="weaver.Clinical_Description"><h3>Clinical Description</h3><p>The phenotypic spectrum associated with <a class="def" href="/books/n/gene/glossary/def-item/germline/">germline</a> <i>EZH2</i> pathogenic variants is broad, with classic Weaver syndrome at one end of the spectrum and tall stature at the other. Although most individuals diagnosed with a <a class="def" href="/books/n/gene/glossary/def-item/heterozygous/">heterozygous</a> germline <i>EZH2</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> have been identified because of a clinical suspicion of Weaver syndrome, a minority have been identified through <a class="def" href="/books/n/gene/glossary/def-item/molecular-genetic-testing/">molecular genetic testing</a> of family members of probands or individuals with overgrowth who did not have a clinical diagnosis of Weaver syndrome [<a class="bk_pop" href="#weaver.REF.tattonbrown.2011.1127">Tatton-Brown et al 2011</a>, <a class="bk_pop" href="#weaver.REF.gibson.2012.110">Gibson et al 2012</a>]. Thus, the extent of the phenotypic spectrum of heterozygous <i>EZH2</i> pathogenic variants is not yet known. While data are still limited, clinical associations reported to date in 54 individuals with Weaver syndrome are summarized below [<a class="bk_pop" href="#weaver.REF.tattonbrown.2011.1127">Tatton-Brown et al 2011</a>, <a class="bk_pop" href="#weaver.REF.gibson.2012.110">Gibson et al 2012</a>, <a class="bk_pop" href="#weaver.REF.alsalem.2013.225">Al-Salem et al 2013</a>, <a class="bk_pop" href="#weaver.REF.tattonbrown.2013.2972">Tatton-Brown et al 2013</a>, <a class="bk_pop" href="#weaver.REF.usemann.2016.1274">Usemann et al 2016</a>, <a class="bk_pop" href="#weaver.REF.suri.2017.2731">Suri &#x00026; Dixit 2017</a>, <a class="bk_pop" href="#weaver.REF.lui.2018.1470">Lui et al 2018</a>]. The denominators reflect the numbers of individuals for whom data are available.</p><p><b>Growth.</b> From data available on 23 newborns, the mean birth length was 2.2 standard deviations above the mean (+2.2 SD) with a range of -0.5 SD to +4.9 SD; the mean birth weight of 45 newborns was +1.7 SD with a range of -1.6 SD to +4.6 SD [<a class="bk_pop" href="#weaver.REF.tattonbrown.2013.2972">Tatton-Brown et al 2013</a>].</p><p>Tall stature is a near-consistent finding: height in 47/52 individuals was at least two standard deviations above the mean (ages 1-70 years). Of note, three of the four individuals with a height less than +2 SD had been tall as young children. The mean postnatal height was +3.5 SD.</p><p>Of 45 individuals on whom information was available, 24 had a head circumference less than +2 SD and 21 had macrocephaly with a head circumference ranging up to +5.5 SD.</p><p><b>Cognitive features.</b> Information on cognitive function was available for 50 individuals. Eight had normal intellect; 42 individuals had variable intellectual disability (ID) including the following:</p><ul><li class="half_rhythm"><div><b>Mild ID</b> (24/50). Children attend mainstream school and need some extra help &#x02013; e.g., a statement of educational needs &#x02013; but would be expected to live independently as adults and would be likely to have their own family.</div></li><li class="half_rhythm"><div><b>Moderate ID</b> (14/50). Children develop speech and need a high level of support in mainstream education but more likely will attend a school for individuals with special educational needs. While unlikely to live independently as adults, they may live in sheltered accommodation or with some additional support.</div></li><li class="half_rhythm"><div><b>Severe ID</b> (2/50). Individuals require special education during schooling and are likely to require considerable support in adulthood.</div></li><li class="half_rhythm"><div><b>Unclassified ID</b> (2/50). Information provided is insufficient to make a determination.</div></li></ul><p><b>Behavioral issues</b> including autistic spectrum disorder, phobias, and anxiety have been anecdotally reported.</p><p><b>Neurologic.</b> Ventriculomegaly, reported in six individuals, was generally associated with normal CSF pressure and did not require shunting [<a class="bk_pop" href="#weaver.REF.tattonbrown.2013.2972">Tatton-Brown et al 2013</a>]. Other brain MRI findings included neuronal migration defects (pachy/polymicrogyria; in 2 individuals), periventricular leukomalacia (2 individuals), and cerebellar abnormalities (2 individuals).</p><p>Intellectual disability in those with a brain MRI abnormality was:</p><ul><li class="half_rhythm"><div>Mild in six (ventriculomegaly [4], periventricular leukomalacia [1], and cerebellar hypoplasia [1]);</div></li><li class="half_rhythm"><div>Moderate in three (periventricular leukomalacia with ventriculomegaly [1] and <a class="def" href="/books/n/gene/glossary/def-item/isolated/">isolated</a> ventriculomegaly [2]);</div></li><li class="half_rhythm"><div>Severe in an individual with polymicrogyria and pachygyria; in contrast, the individual with polymicrogyria reported by <a class="bk_pop" href="#weaver.REF.alsalem.2013.225">Al-Salem et al [2013]</a> had normal developmental milestones and body asymmetry (left side smaller than the right) with brisk reflexes and increased tone on the left.</div></li><li class="half_rhythm"><div>Note: The degree of intellectual disability was not reported for one individual with ventriculomegaly.</div></li></ul><p>Four individuals had afebrile seizures.</p><p><b>Skeletal features</b></p><ul><li class="half_rhythm"><div><b>Advanced bone age.</b> Of 29 individuals evaluated, all had advanced bone age.</div></li><li class="half_rhythm"><div><b>Scoliosis</b> was reported in nine individuals and pectus abnormalities (excavatum or carinatum) in three. Scoliosis ranged from severe (early-childhood onset requiring surgical intervention) to mild (requiring monitoring but no therapeutic intervention).</div></li><li class="half_rhythm"><div><b>Camptodactyly.</b> Some <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals had camptodactyly of the fingers, some had camptodactyly of the toes, and some had camptodactyly of fingers and toes. On occasion the toe camptodactyly required surgical correction.</div></li><li class="half_rhythm"><div><b>Adult boutonniere deformity.</b> Several adults developed hyperextension of the distal interphalangeal joints and flexion of the proximal interphalangeal joints of the hands analogous to a mild boutonniere deformity (<a class="figpopup" href="/books/NBK148820/figure/weaver.F2/?report=objectonly" target="object" rid-figpopup="figweaverF2" rid-ob="figobweaverF2">Figure 2</a>).</div></li><li class="half_rhythm"><div><b>Talipes equinovarus.</b> Six individuals had talipes equinovarus ranging from fixed and bilateral (requiring surgery) in two individuals to mild (unilateral that resolved with physiotherapy) in three.</div></li></ul><div class="iconblock whole_rhythm clearfix ten_col fig" id="figweaverF2" co-legend-rid="figlgndweaverF2"><a href="/books/NBK148820/figure/weaver.F2/?report=objectonly" target="object" title="Figure 2. " class="img_link icnblk_img figpopup" rid-figpopup="figweaverF2" rid-ob="figobweaverF2"><img class="small-thumb" src="/books/NBK148820/bin/weaver-Image002.gif" src-large="/books/NBK148820/bin/weaver-Image002.jpg" alt="Figure 2. " /></a><div class="icnblk_cntnt" id="figlgndweaverF2"><h4 id="weaver.F2"><a href="/books/NBK148820/figure/weaver.F2/?report=objectonly" target="object" rid-ob="figobweaverF2">Figure 2. </a></h4><p class="float-caption no_bottom_margin">Mild hyperextension of the distal interphalangeal joints and flexion of the proximal interphalangeal joints in a woman age 22 years with a heterozygous <i>EZH2</i> pathogenic variant </p></div></div><p><b>Connective tissue</b></p><ul><li class="half_rhythm"><div><b>Ligamentous laxity.</b> While ligamentous laxity with associated joint hypermobility and <i>pes planus</i> is common, it is not usually reported unless complicated by joint pain. Individuals with <i>EZH2</i>-related overgrowth are frequently reported to have poor coordination that may be (at least partially) attributable to lax ligaments.</div></li><li class="half_rhythm"><div><b>Skin</b> that was soft and doughy to the touch was seen in 19/37 <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> children.</div></li><li class="half_rhythm"><div><b>Umbilical hernia,</b> seen in 21/44 children, was sufficiently large to require surgery in the neonatal period in eight.</div></li></ul><p><b>Abnormal tone.</b> In general, if present, abnormal tone (hypotonia, hypertonia, or mixed central hypotonia and peripheral hypertonia) resolved during childhood.</p><ul><li class="half_rhythm"><div class="half_rhythm">Hypotonia (predominantly central) was reported in 22/45 individuals.</div></li><li class="half_rhythm"><div class="half_rhythm">Hypertonia (predominantly peripheral manifesting as stiffness in the limbs with brisk reflexes) was reported in 13/41.</div><div class="half_rhythm">Note: Five of the individuals presenting with peripheral hypertonia were also reported to have central hypotonia.</div></li></ul><p><b>Poor feeding</b> was reported in 10/28 neonates including one who required nasogastric tube feeding for two weeks. Although poor feeding may be attributable to neonatal hypotonia, this was only reported in three of the infants with poor feeding.</p><p><b>Hoarse, low-pitched cry</b> was reported in 10/27 <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> infants.</p><p><b>Tumors</b> have been reported in four of 54 <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals [<a class="bk_pop" href="#weaver.REF.tattonbrown.2013.2972">Tatton-Brown et al 2013</a>, <a class="bk_pop" href="#weaver.REF.usemann.2016.1274">Usemann et al 2016</a>].</p><ul><li class="half_rhythm"><div>One boy with a <a class="figpopup" href="/books/NBK148820/table/weaver.T.ezh2_pathogenic_variants_discus/?report=objectonly" target="object" rid-figpopup="figweaverTezh2pathogenicvariantsdiscus" rid-ob="figobweaverTezh2pathogenicvariantsdiscus">c.2233G&#x0003e;A</a> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> developed a pre-T cell non-Hodgkins lymphoma at age 13 years. At age 25 years he remains well with no relapses or additional tumors.</div></li><li class="half_rhythm"><div>One boy with a <a class="figpopup" href="/books/NBK148820/table/weaver.T.ezh2_pathogenic_variants_discus/?report=objectonly" target="object" rid-figpopup="figweaverTezh2pathogenicvariantsdiscus" rid-ob="figobweaverTezh2pathogenicvariantsdiscus">c.2044G&#x0003e;A</a> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> was diagnosed at age 13 months with acute lymphoblastic leukemia and neuroblastoma, both of which responded to therapy; he is well at age seven years.</div></li><li class="half_rhythm"><div>One girl with a <a class="figpopup" href="/books/NBK148820/table/weaver.T.ezh2_pathogenic_variants_discus/?report=objectonly" target="object" rid-figpopup="figweaverTezh2pathogenicvariantsdiscus" rid-ob="figobweaverTezh2pathogenicvariantsdiscus">c.458A&#x0003e;G</a> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> was diagnosed with a neuroblastoma at age four years.</div></li><li class="half_rhythm"><div>One girl with a <a class="figpopup" href="/books/NBK148820/table/weaver.T.ezh2_pathogenic_variants_discus/?report=objectonly" target="object" rid-figpopup="figweaverTezh2pathogenicvariantsdiscus" rid-ob="figobweaverTezh2pathogenicvariantsdiscus">c.395C&#x0003e;T</a> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> was diagnosed with acute myeloid leukemia and secondary hemophagocytic lymphohistiocytosis at age 16 years.</div></li></ul><p><b>Additional clinical features</b> reported in a small number of individuals (and therefore, possibly not associated with the <i>EZH2</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>) are included for completeness:</p><ul><li class="half_rhythm"><div>Caf&#x000e9; au lait macules (in 2 individuals), hemangioma (in 4)</div></li><li class="half_rhythm"><div>Hypermetropia (hyperopia) (3), myopia (1), strabismus (3)</div></li><li class="half_rhythm"><div>Cryptorchidism (1), hydrocele (2), hypospadias (1)</div></li><li class="half_rhythm"><div>Cleft palate (3)</div></li><li class="half_rhythm"><div>Hearing loss (3) &#x02013; conductive and sensorineural</div></li><li class="half_rhythm"><div>Cardiac anomalies (4) including mitral valve prolapse (1), ventricular septal defect (2), and patent ductus arteriosus (1)</div></li><li class="half_rhythm"><div>Gastroesophageal reflux (1), hiatal hernia (1)</div></li><li class="half_rhythm"><div>Neonatal hypoglycemia (2)</div></li><li class="half_rhythm"><div>Neonatal hypocalcemia (1)</div></li></ul></div><div id="weaver.GenotypePhenotype_Correlations"><h3>Genotype-Phenotype Correlations</h3><p>Because findings along the entire phenotypic spectrum have been observed in individuals with <a class="def" href="/books/n/gene/glossary/def-item/heterozygous/">heterozygous</a> truncating pathogenic variants or heterozygous <a class="def" href="/books/n/gene/glossary/def-item/missense/">missense</a> pathogenic variants, within or outside the conserved SET <a class="def" href="/books/n/gene/glossary/def-item/domain/">domain</a> (see <a href="#weaver.Molecular_Genetics">Molecular Genetics</a>, <b>Normal <a class="def" href="/books/n/gene/glossary/def-item/gene-product/">gene product</a></b>), no <a class="def" href="/books/n/gene/glossary/def-item/genotype-phenotype-correlations/">genotype-phenotype correlations</a> are evident among the small number of individuals reported with <i>EZH2-</i>related overgrowth.</p></div><div id="weaver.Penetrance"><h3>Penetrance</h3><p>Data are currently insufficient to determine <a class="def" href="/books/n/gene/glossary/def-item/penetrance/">penetrance</a> of <i>EZH2</i> <a class="def" href="/books/n/gene/glossary/def-item/germline/">germline</a> pathogenic variants. However, given the subtlety of the <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a> in some persons with a pathogenic <i>EZH2</i> variant, the penetrance for some <i>EZH2</i> pathogenic variants may be reduced [<a class="bk_pop" href="#weaver.REF.tattonbrown.2013.2972">Tatton-Brown et al 2013</a>].</p></div><div id="weaver.Nomenclature"><h3>Nomenclature</h3><p>Weaver syndrome is named after David Weaver, who reported two boys with accelerated osseous maturation, unusual facies, and camptodactyly [<a class="bk_pop" href="#weaver.REF.weaver.1974.547">Weaver et al 1974</a>].</p><p>Although pathogenic variants in <i>NSD1</i> (the cause of <a href="/books/n/gene/sotos/">Sotos syndrome</a>) were once reported to cause Weaver syndrome [<a class="bk_pop" href="#weaver.REF.douglas.2003.132">Douglas et al 2003</a>], this association has been refuted [<a class="bk_pop" href="#weaver.REF.tattonbrown.2005.193">Tatton-Brown et al 2005</a>].</p></div><div id="weaver.Prevalence"><h3>Prevalence</h3><p>Because <i>EZH2</i> pathogenic variants have only recently been shown to cause Weaver syndrome, and individuals with a mild <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a> may escape clinical diagnosis, it is currently difficult to estimate the prevalence of Weaver syndrome.</p></div></div><div id="weaver.Genetically_Related_Allelic_Disor"><h2 id="_weaver_Genetically_Related_Allelic_Disor_">Genetically Related (Allelic) Disorders</h2><p>No phenotypes other than those discussed in this <i>GeneReview</i> are known to be associated with <a class="def" href="/books/n/gene/glossary/def-item/germline/">germline</a> pathogenic variants in <i>EZH2</i>.</p><p>Sporadic tumors (including hematopoietic malignancies) occurring in the absence of any other findings of Weaver syndrome frequently harbor somatic variants in <i>EZH2</i> that are <b>not</b> present in the <a class="def" href="/books/n/gene/glossary/def-item/germline/">germline</a>. In these circumstances predisposition to these tumors is not heritable. For more information see <a href="#weaver.Cancer_and_Benign_Tumors">Cancer and Benign Tumors</a>.</p></div><div id="weaver.Differential_Diagnosis"><h2 id="_weaver_Differential_Diagnosis_">Differential Diagnosis</h2><p>Conditions to be considered in the differential diagnosis of Weaver syndrome are summarized in <a class="figpopup" href="/books/NBK148820/table/weaver.T.disorders_to_consider_in_the_di/?report=objectonly" target="object" rid-figpopup="figweaverTdisorderstoconsiderinthedi" rid-ob="figobweaverTdisorderstoconsiderinthedi">Table 2</a>.</p><div id="weaver.T.disorders_to_consider_in_the_di" class="table"><h3><span class="label">Table 2. </span></h3><div class="caption"><p>Disorders to Consider in the Differential Diagnosis of Weaver Syndrome</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK148820/table/weaver.T.disorders_to_consider_in_the_di/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__weaver.T.disorders_to_consider_in_the_di_lrgtbl__"><table class="no_bottom_margin"><thead><tr><th id="hd_h_weaver.T.disorders_to_consider_in_the_di_1_1_1_1" rowspan="2" scope="col" colspan="1" headers="hd_h_weaver.T.disorders_to_consider_in_the_di_1_1_1_1" style="text-align:left;vertical-align:middle;">Disorder</th><th id="hd_h_weaver.T.disorders_to_consider_in_the_di_1_1_1_2" rowspan="2" scope="col" colspan="1" headers="hd_h_weaver.T.disorders_to_consider_in_the_di_1_1_1_2" style="text-align:left;vertical-align:middle;">Gene / Genetic Mechanism</th><th id="hd_h_weaver.T.disorders_to_consider_in_the_di_1_1_1_3" rowspan="2" scope="col" colspan="1" headers="hd_h_weaver.T.disorders_to_consider_in_the_di_1_1_1_3" style="text-align:left;vertical-align:middle;">MOI</th><th id="hd_h_weaver.T.disorders_to_consider_in_the_di_1_1_1_4" colspan="2" scope="colgroup" rowspan="1" style="text-align:center;vertical-align:middle;">Clinical Features</th></tr><tr><th headers="hd_h_weaver.T.disorders_to_consider_in_the_di_1_1_1_4" id="hd_h_weaver.T.disorders_to_consider_in_the_di_1_1_2_1" colspan="1" scope="colgroup" rowspan="1" style="text-align:left;vertical-align:middle;">Overlapping</th><th headers="hd_h_weaver.T.disorders_to_consider_in_the_di_1_1_1_4" id="hd_h_weaver.T.disorders_to_consider_in_the_di_1_1_2_2" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Distinguishing</th></tr></thead><tbody><tr><td headers="hd_h_weaver.T.disorders_to_consider_in_the_di_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a href="/books/n/gene/sotos/">Sotos syndrome</a></td><td headers="hd_h_weaver.T.disorders_to_consider_in_the_di_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>NSD1</i>&#x000a0;<sup>1</sup></td><td headers="hd_h_weaver.T.disorders_to_consider_in_the_di_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">AD&#x000a0;<sup>2</sup></td><td headers="hd_h_weaver.T.disorders_to_consider_in_the_di_1_1_1_4 hd_h_weaver.T.disorders_to_consider_in_the_di_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><ul><li class="half_rhythm"><div>Pre- &#x00026; postnatal overgrowth</div></li><li class="half_rhythm"><div>Variable ID</div></li><li class="half_rhythm"><div>Similar (but distinctive; see <b>Distinguishing</b> &#x02192;) facial appearance</div></li><li class="half_rhythm"><div>Advanced bone age</div></li><li class="half_rhythm"><div>Scoliosis</div></li><li class="half_rhythm"><div>Joint hypermobility</div></li></ul>
</td><td headers="hd_h_weaver.T.disorders_to_consider_in_the_di_1_1_1_4 hd_h_weaver.T.disorders_to_consider_in_the_di_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Facial features in Sotos syndrome:
<ul><li class="half_rhythm"><div>Downslanted palpebral fissures, prominent chin, malar flushing in children</div></li><li class="half_rhythm"><div>Most easily distinguishable from Weaver syndrome at ages 1-3</div></li></ul>
</td></tr><tr><td headers="hd_h_weaver.T.disorders_to_consider_in_the_di_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Malan syndrome (OMIM <a href="http://omim.org/entry/614753" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">614753</a>)</td><td headers="hd_h_weaver.T.disorders_to_consider_in_the_di_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>NFIX</i></td><td headers="hd_h_weaver.T.disorders_to_consider_in_the_di_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">AD</td><td headers="hd_h_weaver.T.disorders_to_consider_in_the_di_1_1_1_4 hd_h_weaver.T.disorders_to_consider_in_the_di_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><ul><li class="half_rhythm"><div>Sotos syndrome-like condition</div></li><li class="half_rhythm"><div>Tall stature</div></li><li class="half_rhythm"><div>Variable ID&#x000a0;<sup>3</sup></div></li></ul>
</td><td headers="hd_h_weaver.T.disorders_to_consider_in_the_di_1_1_1_4 hd_h_weaver.T.disorders_to_consider_in_the_di_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">In Malan syndrome:
<ul><li class="half_rhythm"><div>Ophthalmologic abnormalities common</div></li><li class="half_rhythm"><div>Growth frequently normalizes in teenagers &#x00026; young adults</div></li></ul>
</td></tr><tr><td headers="hd_h_weaver.T.disorders_to_consider_in_the_di_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">DNMT3A overgrowth (Tatton-Brown-Rahman) syndrome (OMIM <a href="http://omim.org/entry/615879" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">615879</a>)</td><td headers="hd_h_weaver.T.disorders_to_consider_in_the_di_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>DNMT3A<sup>4</sup></i></td><td headers="hd_h_weaver.T.disorders_to_consider_in_the_di_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">AD</td><td headers="hd_h_weaver.T.disorders_to_consider_in_the_di_1_1_1_4 hd_h_weaver.T.disorders_to_consider_in_the_di_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><ul><li class="half_rhythm"><div>Tall stature</div></li><li class="half_rhythm"><div>Variable ID</div></li><li class="half_rhythm"><div>ASD</div></li><li class="half_rhythm"><div>Scoliosis</div></li><li class="half_rhythm"><div>Joint hypermobility</div></li></ul>
</td><td headers="hd_h_weaver.T.disorders_to_consider_in_the_di_1_1_1_4 hd_h_weaver.T.disorders_to_consider_in_the_di_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">In DNMT3A overgrowth syndrome:
<ul><li class="half_rhythm"><div>Facial appearance (round, heavy; w/horizontal eyebrows &#x00026; narrow palpebral fissures) most recognizable in early teen/adult yrs</div></li><li class="half_rhythm"><div>&#x02191; weight</div></li><li class="half_rhythm"><div>Neuropsychiatric issues</div></li></ul>
</td></tr><tr><td headers="hd_h_weaver.T.disorders_to_consider_in_the_di_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a href="/books/n/gene/bws/">Beckwith-Wiedeman syndrome</a> (BWS)</td><td headers="hd_h_weaver.T.disorders_to_consider_in_the_di_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Abnormal regulation of <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> transcription in two <a class="def" href="/books/n/gene/glossary/def-item/imprinted/">imprinted</a> domains at 11p15.5&#x000a0;<sup>5</sup></td><td headers="hd_h_weaver.T.disorders_to_consider_in_the_di_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Footnote 6</td><td headers="hd_h_weaver.T.disorders_to_consider_in_the_di_1_1_1_4 hd_h_weaver.T.disorders_to_consider_in_the_di_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><ul><li class="half_rhythm"><div>&#x02191; birth weight</div></li><li class="half_rhythm"><div>Tall stature (not as frequent in BWS as the other conditions in the differential diagnosis)</div></li><li class="half_rhythm"><div>Umbilical hernia</div></li></ul>
</td><td headers="hd_h_weaver.T.disorders_to_consider_in_the_di_1_1_1_4 hd_h_weaver.T.disorders_to_consider_in_the_di_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">In BWS:
<ul><li class="half_rhythm"><div>Macroglossia</div></li><li class="half_rhythm"><div>Earlobe creases/pits</div></li><li class="half_rhythm"><div>Omphalocele</div></li><li class="half_rhythm"><div>Visceromegaly</div></li><li class="half_rhythm"><div>Usually normal intellect</div></li><li class="half_rhythm"><div>Neonatal hypoglycemia</div></li><li class="half_rhythm"><div>Polyhydramnios</div></li><li class="half_rhythm"><div>Predisposition to embryonal tumors, esp Wilms tumor</div></li></ul>
</td></tr><tr><td headers="hd_h_weaver.T.disorders_to_consider_in_the_di_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a href="/books/n/gene/sgbs/">Simpson-Golabi-Behmel syndrome type 1</a> (SGBS1)</td><td headers="hd_h_weaver.T.disorders_to_consider_in_the_di_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>GPC3</i><br />(possibly <i>GPC4</i>)</td><td headers="hd_h_weaver.T.disorders_to_consider_in_the_di_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">XL</td><td headers="hd_h_weaver.T.disorders_to_consider_in_the_di_1_1_1_4 hd_h_weaver.T.disorders_to_consider_in_the_di_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><ul><li class="half_rhythm"><div>&#x02191; birth weight</div></li><li class="half_rhythm"><div>Tall stature</div></li><li class="half_rhythm"><div>Variable ID</div></li></ul>
</td><td headers="hd_h_weaver.T.disorders_to_consider_in_the_di_1_1_1_4 hd_h_weaver.T.disorders_to_consider_in_the_di_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">In SGBS1:
<ul><li class="half_rhythm"><div>Characteristic facial appearance</div></li><li class="half_rhythm"><div>Supernumerary nipples</div></li><li class="half_rhythm"><div>Polydactyly</div></li><li class="half_rhythm"><div>Diastasis recti&#x000a0;<sup>7</sup></div></li></ul>
</td></tr><tr><td headers="hd_h_weaver.T.disorders_to_consider_in_the_di_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a href="/books/n/gene/marfan/">Marfan syndrome</a></td><td headers="hd_h_weaver.T.disorders_to_consider_in_the_di_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>FBN1</i></td><td headers="hd_h_weaver.T.disorders_to_consider_in_the_di_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">AD</td><td headers="hd_h_weaver.T.disorders_to_consider_in_the_di_1_1_1_4 hd_h_weaver.T.disorders_to_consider_in_the_di_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><ul><li class="half_rhythm"><div>Tall stature</div></li><li class="half_rhythm"><div>Scoliosis</div></li><li class="half_rhythm"><div>Joint hypermobility</div></li></ul>
</td><td headers="hd_h_weaver.T.disorders_to_consider_in_the_di_1_1_1_4 hd_h_weaver.T.disorders_to_consider_in_the_di_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">In Marfan syndrome:
<ul><li class="half_rhythm"><div>Cognitive abilities usually normal</div></li><li class="half_rhythm"><div>Ocular findings (myopia &#x00026; lens dislocation)</div></li><li class="half_rhythm"><div>Cardiovascular findings (dilatation of the aorta; mitral &#x00026; tricuspid valve prolapse)</div></li><li class="half_rhythm"><div>Pectus abnormalities common</div></li></ul>
</td></tr><tr><td headers="hd_h_weaver.T.disorders_to_consider_in_the_di_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a href="/books/n/gene/cca/">Congenital contractural arachnodactyly</a> (CCA; Beals syndrome)</td><td headers="hd_h_weaver.T.disorders_to_consider_in_the_di_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>FBN2</i></td><td headers="hd_h_weaver.T.disorders_to_consider_in_the_di_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">AD</td><td headers="hd_h_weaver.T.disorders_to_consider_in_the_di_1_1_1_4 hd_h_weaver.T.disorders_to_consider_in_the_di_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><ul><li class="half_rhythm"><div>Tall stature</div></li><li class="half_rhythm"><div>Scoliosis</div></li><li class="half_rhythm"><div>Camptodactyly</div></li></ul>
</td><td headers="hd_h_weaver.T.disorders_to_consider_in_the_di_1_1_1_4 hd_h_weaver.T.disorders_to_consider_in_the_di_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">In CCA:
<ul><li class="half_rhythm"><div>Cognitive abilities usually normal</div></li><li class="half_rhythm"><div>Cardiovascular findings (dilatation of the aorta; mitral &#x00026; tricuspid valve prolapse)</div></li><li class="half_rhythm"><div>Crumpled appearance to the top of the ear</div></li><li class="half_rhythm"><div>Pectus abnormalities common</div></li></ul>
</td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt></dt><dd><div><p class="no_margin">AD = <a class="def" href="/books/n/gene/glossary/def-item/autosomal-dominant/">autosomal dominant</a>; ASD = autism spectrum disorder; ID = intellectual disability; MOI = <a class="def" href="/books/n/gene/glossary/def-item/mode-of-inheritance/">mode of inheritance</a>; XL = <a class="def" href="/books/n/gene/glossary/def-item/x-linked/">X-linked</a></p></div></dd><dt>1. </dt><dd><div id="weaver.TF.2.1"><p class="no_margin">Pathogenic variants in <i>NSD1</i> (the cause of <a href="/books/n/gene/sotos/">Sotos syndrome</a>) were once reported to cause Weaver syndrome [<a class="bk_pop" href="#weaver.REF.douglas.2003.132">Douglas et al 2003</a>]. However, this association has been refuted [<a class="bk_pop" href="#weaver.REF.tattonbrown.2005.193">Tatton-Brown et al 2005</a>].</p></div></dd><dt>2. </dt><dd><div id="weaver.TF.2.2"><p class="no_margin">More than 95% of individuals have a <a class="def" href="/books/n/gene/glossary/def-item/de-novo/"><i>de novo</i></a> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>.</p></div></dd><dt>3. </dt><dd><div id="weaver.TF.2.3"><p class="no_margin"><a class="bk_pop" href="#weaver.REF.malan.2010.189">Malan et al [2010]</a>, <a class="bk_pop" href="#weaver.REF.schanze.2014.1092">Schanze et al [2014]</a>, <a class="bk_pop" href="#weaver.REF.klaassens.2015.610">Klaassens et al [2015]</a>, <a class="bk_pop" href="#weaver.REF.priolo.2018.1226">Priolo et al [2018]</a></p></div></dd><dt>4. </dt><dd><div id="weaver.TF.2.4"><p class="no_margin"><a class="bk_pop" href="#weaver.REF.tattonbrown.2014.385">Tatton-Brown et al [2014]</a>, <a class="bk_pop" href="#weaver.REF.tattonbrown.2018.46">Tatton-Brown et al [2018]</a></p></div></dd><dt>5. </dt><dd><div id="weaver.TF.2.5"><p class="no_margin">A clinical suspicion of BWS can be confirmed through testing that reveals dysregulation of the normal imprint at the 11p15 growth regulatory region [<a class="bk_pop" href="#weaver.REF.choufani.2010.343">Choufani et al 2010</a>]: loss of <a class="def" href="/books/n/gene/glossary/def-item/methylation/">methylation</a> at <a class="def" href="/books/n/gene/glossary/def-item/imprinting/">imprinting</a> center 2 (IC2; see <a href="/books/n/gene/bws/figure/bws.F1/?report=objectonly" target="object" class="figpopup" rid-figpopup="figbwsF1" rid-ob="figobbwsF1">Beckwith-Wiedeman Syndrome, Figure 1</a> for detailed molecular mechanism) on the maternal <a class="def" href="/books/n/gene/glossary/def-item/allele/">allele</a> (in ~50% of <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals); <a class="def" href="/books/n/gene/glossary/def-item/uniparental-disomy/">uniparental disomy</a> for 11p15 (in ~20% of affected individuals); gain of methylation at imprinting center 1 (IC12; see <a href="/books/n/gene/bws/figure/bws.F1/?report=objectonly" target="object" class="figpopup" rid-figpopup="figbwsF1" rid-ob="figobbwsF1">Beckwith-Wiedeman Syndrome, Figure 1</a> for detailed molecular mechanism) of the maternal allele (in ~5% of affected individuals); or pathogenic variants within the maternal copy of <i>CDKN1C</i> (in 5%-10% of <a class="def" href="/books/n/gene/glossary/def-item/sporadic/">sporadic</a> cases of BWS; &#x02264;40% of <a class="def" href="/books/n/gene/glossary/def-item/familial/">familial</a> cases). In approximately 20% of individuals with a clinical diagnosis of BWS the underlying molecular abnormality is not elucidated.</p></div></dd><dt>6. </dt><dd><div id="weaver.TF.2.6"><p class="no_margin">Approximately 85% of individuals with BWS have no family history of BWS; approximately 15% have a family history consistent with parent-of-origin <a class="def" href="/books/n/gene/glossary/def-item/autosomal-dominant/">autosomal dominant</a> transmission.</p></div></dd><dt>7. </dt><dd><div id="weaver.TF.2.7"><p class="no_margin"><a class="bk_pop" href="#weaver.REF.golabi.1984.345">Golabi &#x00026; Rosen [1984]</a>, <a class="bk_pop" href="#weaver.REF.cottereau.2013.92">Cottereau et al [2013]</a></p></div></dd></dl></div></div></div></div><div id="weaver.Management"><h2 id="_weaver_Management_">Management</h2><p>The following information represents typical evaluation and management recommendations for individuals in the United States; standard recommendations may vary from country to country [Author, personal observation].</p><div id="weaver.Evaluations_Following_Initial_Dia"><h3>Evaluations Following Initial Diagnosis</h3><p>To establish the extent of disease and needs of an individual diagnosed with a <a class="def" href="/books/n/gene/glossary/def-item/heterozygous/">heterozygous</a> <i>EZH2</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>, the evaluations summarized in <a class="figpopup" href="/books/NBK148820/table/weaver.T.recommended_evaluations_followi/?report=objectonly" target="object" rid-figpopup="figweaverTrecommendedevaluationsfollowi" rid-ob="figobweaverTrecommendedevaluationsfollowi">Table 3</a> (if not performed as part of the evaluation that led to the diagnosis) are recommended.</p><div id="weaver.T.recommended_evaluations_followi" class="table"><h3><span class="label">Table 3. </span></h3><div class="caption"><p>Recommended Evaluations Following Initial Diagnosis in Individuals with <i>EZH2-</i>Related Overgrowth</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK148820/table/weaver.T.recommended_evaluations_followi/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__weaver.T.recommended_evaluations_followi_lrgtbl__"><table class="no_bottom_margin"><thead><tr><th id="hd_h_weaver.T.recommended_evaluations_followi_1_1_1_1" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">System/<br />Concern</th><th id="hd_h_weaver.T.recommended_evaluations_followi_1_1_1_2" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Evaluation</th><th id="hd_h_weaver.T.recommended_evaluations_followi_1_1_1_3" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Comment</th></tr></thead><tbody><tr><td headers="hd_h_weaver.T.recommended_evaluations_followi_1_1_1_1" rowspan="3" scope="row" colspan="1" style="text-align:left;vertical-align:middle;"><b>Neurologic</b></td><td headers="hd_h_weaver.T.recommended_evaluations_followi_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Developmental assessment</td><td headers="hd_h_weaver.T.recommended_evaluations_followi_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">To incl motor, speech/language evaluation, general cognitive, &#x00026; vocational skills</td></tr><tr><td headers="hd_h_weaver.T.recommended_evaluations_followi_1_1_1_2" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">Muscle tone</td><td headers="hd_h_weaver.T.recommended_evaluations_followi_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Hypotonia &#x00026; mixed hypo/hypertonia common</td></tr><tr><td headers="hd_h_weaver.T.recommended_evaluations_followi_1_1_1_2" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">Seizures</td><td headers="hd_h_weaver.T.recommended_evaluations_followi_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">If seizure activity is suspected:
<ul><li class="half_rhythm"><div>Brain MRI</div></li><li class="half_rhythm"><div>EEG</div></li></ul>
</td></tr><tr><td headers="hd_h_weaver.T.recommended_evaluations_followi_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>Psychiatric/</b><br /><b>Behavioral</b></td><td headers="hd_h_weaver.T.recommended_evaluations_followi_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Assessment for ASD &#x00026; other behavioral issues</td><td headers="hd_h_weaver.T.recommended_evaluations_followi_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td></tr><tr><td headers="hd_h_weaver.T.recommended_evaluations_followi_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>Constitutional</b></td><td headers="hd_h_weaver.T.recommended_evaluations_followi_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Measurement of height, weight, head circumference</td><td headers="hd_h_weaver.T.recommended_evaluations_followi_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td></tr><tr><td headers="hd_h_weaver.T.recommended_evaluations_followi_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>Musculoskeletal</b></td><td headers="hd_h_weaver.T.recommended_evaluations_followi_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Assessment for scoliosis, camptodactyly, ligamentous laxity</td><td headers="hd_h_weaver.T.recommended_evaluations_followi_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td></tr><tr><td headers="hd_h_weaver.T.recommended_evaluations_followi_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>Genitourinary</b></td><td headers="hd_h_weaver.T.recommended_evaluations_followi_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Assessment for cryptorchidism, hydrocele, hypospadias</td><td headers="hd_h_weaver.T.recommended_evaluations_followi_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td></tr><tr><td headers="hd_h_weaver.T.recommended_evaluations_followi_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>Cardiovascular</b></td><td headers="hd_h_weaver.T.recommended_evaluations_followi_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Cardiac auscultation</td><td headers="hd_h_weaver.T.recommended_evaluations_followi_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Baseline echocardiogram for evidence of structural cardiac anomalies</td></tr><tr><td headers="hd_h_weaver.T.recommended_evaluations_followi_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>Malignancy</b></td><td headers="hd_h_weaver.T.recommended_evaluations_followi_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Assessment for potential malignancy, esp neuroblastoma &#x00026; hematologic malignancies</td><td headers="hd_h_weaver.T.recommended_evaluations_followi_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">While no specific surveillance is recommended, a low threshold for investigation of any possible tumor-related symptoms is advised.</td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt></dt><dd><div><p class="no_margin">ASD = autism spectrum disorder</p></div></dd></dl></div></div></div></div><div id="weaver.Treatment_of_Manifestations"><h3>Treatment of Manifestations</h3><div id="weaver.T.treatment_of_manifestations_in" class="table"><h3><span class="label">Table 4. </span></h3><div class="caption"><p>Treatment of Manifestations in Individuals with <i>EZH2-</i>Related Overgrowth</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK148820/table/weaver.T.treatment_of_manifestations_in/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__weaver.T.treatment_of_manifestations_in_lrgtbl__"><table><thead><tr><th id="hd_h_weaver.T.treatment_of_manifestations_in_1_1_1_1" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Manifestation/Concern</th><th id="hd_h_weaver.T.treatment_of_manifestations_in_1_1_1_2" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Treatment</th><th id="hd_h_weaver.T.treatment_of_manifestations_in_1_1_1_3" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Considerations/Other</th></tr></thead><tbody><tr><td headers="hd_h_weaver.T.treatment_of_manifestations_in_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Developmental delay &#x00026;/or learning disability</td><td headers="hd_h_weaver.T.treatment_of_manifestations_in_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Educational support</td><td headers="hd_h_weaver.T.treatment_of_manifestations_in_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Referral for learning/behavior/speech assessment &#x00026; support may be indicated.</td></tr><tr><td headers="hd_h_weaver.T.treatment_of_manifestations_in_1_1_1_1" rowspan="2" scope="row" colspan="1" style="text-align:left;vertical-align:middle;">Camptodactyly</td><td headers="hd_h_weaver.T.treatment_of_manifestations_in_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Surgical intervention</td><td headers="hd_h_weaver.T.treatment_of_manifestations_in_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Occasionally toe camptodactyly may require surgical intervention.</td></tr><tr><td headers="hd_h_weaver.T.treatment_of_manifestations_in_1_1_1_2" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">Physiotherapy</td><td headers="hd_h_weaver.T.treatment_of_manifestations_in_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">May be beneficial</td></tr><tr><td headers="hd_h_weaver.T.treatment_of_manifestations_in_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Abnormal muscle tone</td><td headers="hd_h_weaver.T.treatment_of_manifestations_in_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Physiotherapy</td><td headers="hd_h_weaver.T.treatment_of_manifestations_in_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">May be beneficial</td></tr><tr><td headers="hd_h_weaver.T.treatment_of_manifestations_in_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Ligamentous laxity</td><td headers="hd_h_weaver.T.treatment_of_manifestations_in_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Physiotherapy</td><td headers="hd_h_weaver.T.treatment_of_manifestations_in_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">May reduce joint pain secondary to ligamentous laxity</td></tr><tr><td headers="hd_h_weaver.T.treatment_of_manifestations_in_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Scoliosis</td><td headers="hd_h_weaver.T.treatment_of_manifestations_in_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Further evaluation &#x00026; monitoring</td><td headers="hd_h_weaver.T.treatment_of_manifestations_in_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Referral to orthopedist</td></tr></tbody></table></div></div><p>If additional clinical issues are detected through the history and/or examination, the appropriate specialist referral(s) should be made.</p><div id="weaver.Global_Developmental_Disability"><h4>Global Developmental Disability / Intellectual Disability Management Issues</h4><p><b>Ages 0-3 years.</b> Referral to an early intervention program is recommended for access to occupational, physical, speech, and feeding therapy. In the United States, early intervention is a federally funded program available in all states.</p><p><b>Ages 3-5 years.</b> In the US, developmental preschool through the local public school district is recommended. Before placement, an evaluation is made to determine needed services and therapies and an individualized education plan (IEP) is developed.</p><p><b>Ages 5-21 years</b></p><ul><li class="half_rhythm"><div>In the US, an IEP based on the individual's level of function should be developed by the local public school district. Affected children are permitted to remain in the public school system until age 21.</div></li><li class="half_rhythm"><div>Discussion about transition plans including financial, vocation/employment if feasible, and medical arrangements should begin at age 12 years. Developmental pediatricians can provide assistance with transition to adulthood.</div></li></ul><p><b>All ages.</b> Consultation with a developmental pediatrician is recommended to ensure the involvement of appropriate community, state, and educational agencies and to support parents in maximizing quality of life.</p><p>Consideration of private supportive therapies based on the <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individual's needs is recommended. Specific recommendations regarding type of therapy can be made by a developmental pediatrician.</p><p>In the US:</p><ul><li class="half_rhythm"><div>Developmental Disabilities Administration (DDA) enrollment is recommended. DDA is a public agency that provides services and support to qualified individuals. Eligibility differs by state but is typically determined by diagnosis and/or associated cognitive/adaptive disabilities.</div></li><li class="half_rhythm"><div>Families with limited income and resources may also qualify for supplemental security income (SSI) for their child with a disability.</div></li></ul></div><div id="weaver.Motor_Dysfunction"><h4>Motor Dysfunction</h4><p><b>Gross motor dysfunction</b></p><ul><li class="half_rhythm"><div>Physical therapy is recommended to maximize mobility.</div></li><li class="half_rhythm"><div>Consider use of durable medical equipment as needed (e.g., wheelchairs, walkers, bath chairs, orthotics, adaptive strollers).</div></li></ul><p><b>Fine motor dysfunction.</b> Occupational therapy is recommended for difficulty with fine motor skills that affect adaptive function such as feeding, grooming, dressing, and writing.</p><p><b>Oral motor dysfunction.</b> Assuming that the individual is safe to eat by mouth, feeding therapy &#x02013; typically from an occupational or speech therapist &#x02013; is recommended for <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals who have difficulty feeding due to poor oral motor control.</p><p><b>Communication issues.</b> Consider evaluation for alternative means of communication (e.g., <a href="http://www.asha.org/NJC/AAC/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Augmentative and Alternative Communication</a> [AAC]) for individuals who have expressive language difficulties.</p></div></div><div id="weaver.Surveillance"><h3>Surveillance</h3><div id="weaver.T.recommended_surveillance_for_in" class="table"><h3><span class="label">Table 5. </span></h3><div class="caption"><p>Recommended Surveillance for Individuals with <i>EZH2-</i>Related Overgrowth</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK148820/table/weaver.T.recommended_surveillance_for_in/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__weaver.T.recommended_surveillance_for_in_lrgtbl__"><table class="no_bottom_margin"><thead><tr><th id="hd_h_weaver.T.recommended_surveillance_for_in_1_1_1_1" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">System/Concern</th><th id="hd_h_weaver.T.recommended_surveillance_for_in_1_1_1_2" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Evaluation</th><th id="hd_h_weaver.T.recommended_surveillance_for_in_1_1_1_3" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Frequency&#x000a0;<sup>1</sup></th></tr></thead><tbody><tr><td headers="hd_h_weaver.T.recommended_surveillance_for_in_1_1_1_1" rowspan="2" scope="row" colspan="1" style="text-align:left;vertical-align:middle;"><b>Musculoskeletal</b></td><td headers="hd_h_weaver.T.recommended_surveillance_for_in_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Monitoring by pediatrician for resolution/improvement of camptodactyly &#x00026;/or hypotonia</td><td headers="hd_h_weaver.T.recommended_surveillance_for_in_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Regular follow up w/frequency dependent on severity</td></tr><tr><td headers="hd_h_weaver.T.recommended_surveillance_for_in_1_1_1_2" colspan="1" scope="col" rowspan="1" style="text-align:left;vertical-align:middle;">If scoliosis is present, monitoring per orthopedic recommendations</td><td headers="hd_h_weaver.T.recommended_surveillance_for_in_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td></tr><tr><td headers="hd_h_weaver.T.recommended_surveillance_for_in_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>Malignancy</b></td><td headers="hd_h_weaver.T.recommended_surveillance_for_in_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Neuroblastoma surveillance: current recommendations include clinical vigilance &#x00026; thorough investigation of any symptoms that may be tumor related.&#x000a0;<sup>2</sup><br />Note: Neuroblastoma surveillance has been inconsistent, w/no data supporting modality of surveillance, screening interval, or duration.</td><td headers="hd_h_weaver.T.recommended_surveillance_for_in_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td></tr><tr><td headers="hd_h_weaver.T.recommended_surveillance_for_in_1_1_1_1" rowspan="2" scope="row" colspan="1" style="text-align:left;vertical-align:middle;"><b>Miscellaneous/</b><br /><b>Other</b></td><td headers="hd_h_weaver.T.recommended_surveillance_for_in_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Monitoring of developmental progress &#x00026; educational needs</td><td headers="hd_h_weaver.T.recommended_surveillance_for_in_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Regular follow up w/frequency dependent on severity</td></tr><tr><td headers="hd_h_weaver.T.recommended_surveillance_for_in_1_1_1_2" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">Clinical genetics evaluation</td><td headers="hd_h_weaver.T.recommended_surveillance_for_in_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">At diagnosis, soon after to answer further questions, &#x00026; when appropriate to support reproductive decisions (i.e., for parents to discuss <a class="def" href="/books/n/gene/glossary/def-item/recurrence-risk/">recurrence risk</a> or for <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals to discuss offspring risk)</td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt>1. </dt><dd><div id="weaver.TF.5.1"><p class="no_margin">In older children/teenagers who do not have medical complications, the clinician may wish to review less frequently than in yonger children.</p></div></dd><dt>2. </dt><dd><div id="weaver.TF.5.2"><p class="no_margin">Current data suggest a slightly increased relative risk for the development of neuroblastoma in individuals with <a class="def" href="/books/n/gene/glossary/def-item/heterozygous/">heterozygous</a> <a class="def" href="/books/n/gene/glossary/def-item/germline/">germline</a> <i>EZH2</i> pathogenic variants. Although the numbers are too small to quantify the absolute tumor risk, it appears to be low (see <a href="#weaver.Clinical_Description">Clinical Description</a>, <b>Tumors</b>).</p></div></dd></dl></div></div></div></div><div id="weaver.Evaluation_of_Relatives_at_Risk"><h3>Evaluation of Relatives at Risk</h3><p>See <a href="#weaver.Related_Genetic_Counseling_Issues">Genetic Counseling</a> for issues related to testing of at-risk relatives for <a class="def" href="/books/n/gene/glossary/def-item/genetic-counseling/">genetic counseling</a> purposes.</p></div><div id="weaver.Pregnancy_Management"><h3>Pregnancy Management</h3><p>In general, pregnancies in which the mother and/or fetus has a <a class="def" href="/books/n/gene/glossary/def-item/heterozygous/">heterozygous</a> <i>EZH2</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> are uncomplicated. Families and their health care providers should be aware that an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> baby may be large so that appropriate delivery plans can be made; in addition, information about the <i>EZH2-</i>related overgrowth <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a> should be provided.</p></div><div id="weaver.Therapies_Under_Investigation"><h3>Therapies Under Investigation</h3><p>Search <a href="http://clinicaltrials.gov/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">ClinicalTrials.gov</a> in the US and <a href="http://www.clinicaltrialsregister.eu/ctr-search/search" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">EU Clinical Trials Register</a> in Europe for access to information on clinical studies for a wide range of diseases and conditions. Note: There may not be clinical trials for this disorder.</p></div></div><div id="weaver.Genetic_Counseling"><h2 id="_weaver_Genetic_Counseling_">Genetic Counseling</h2><p>
<i>Genetic counseling is the process of providing individuals and families with
information on the nature, inheritance, and implications of genetic disorders to help them
make informed medical and personal decisions. The following section deals with genetic
risk assessment and the use of family history and genetic testing to clarify genetic
status for family members. This section is not meant to address all personal, cultural, or
ethical issues that individuals may face or to substitute for consultation with a genetics
professional</i>. &#x02014;ED.</p><div id="weaver.Mode_of_Inheritance"><h3>Mode of Inheritance</h3><p><i>EZH2-</i>related overgrowth is inherited in an <a class="def" href="/books/n/gene/glossary/def-item/autosomal-dominant/">autosomal dominant</a> manner.</p></div><div id="weaver.Risk_to_Family_Members"><h3>Risk to Family Members</h3><p><b>Parents of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a></b></p><ul><li class="half_rhythm"><div>Some individuals diagnosed with <i>EZH2-</i>related overgrowth have an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> parent.</div></li><li class="half_rhythm"><div>Some individuals diagnosed with <i>EZH2</i>-related overgrowth have the disorder as the result of a <i>de novo EZH2</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>. The proportion of <i>EZH2-</i>related overgrowth caused by a <a class="def" href="/books/n/gene/glossary/def-item/de-novo/"><i>de novo</i></a> pathogenic variant is unknown. In the series of 48 individuals identified with an <i>EZH2</i> pathogenic variant [<a class="bk_pop" href="#weaver.REF.tattonbrown.2013.2972">Tatton-Brown et al 2013</a>]:</div><ul><li class="half_rhythm"><div>23 were <a class="def" href="/books/n/gene/glossary/def-item/simplex/">simplex</a> cases with a <a class="def" href="/books/n/gene/glossary/def-item/de-novo/"><i>de novo</i></a> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>.</div></li><li class="half_rhythm"><div>14 were <a class="def" href="/books/n/gene/glossary/def-item/familial/">familial</a> cases.</div></li><li class="half_rhythm"><div>11 could not be confirmed as having a <a class="def" href="/books/n/gene/glossary/def-item/de-novo/"><i>de novo</i></a> or a <a class="def" href="/books/n/gene/glossary/def-item/familial/">familial</a> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> as parental testing was not performed or clinical information was not available from a parent.</div></li></ul></li><li class="half_rhythm"><div>Molecular genetic testing is recommended for the parents of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> with an apparent <a class="def" href="/books/n/gene/glossary/def-item/de-novo/"><i>de novo</i></a> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>.</div></li><li class="half_rhythm"><div>If the <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> found in the <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> cannot be detected in the leukocyte DNA of either parent, possible explanations include a <a class="def" href="/books/n/gene/glossary/def-item/de-novo/"><i>de novo</i></a> <a class="def" href="/books/n/gene/glossary/def-item/germline/">germline</a> <i>EZH2</i> pathogenic variant in the proband or <a class="def" href="/books/n/gene/glossary/def-item/germline-mosaicism/">germline mosaicism</a> in a parent (although no instances of germline mosaicism have been reported it remains a possibility).</div></li><li class="half_rhythm"><div>Evaluation of parents may determine that one has a <a class="def" href="/books/n/gene/glossary/def-item/heterozygous/">heterozygous</a> <a class="def" href="/books/n/gene/glossary/def-item/germline/">germline</a> <i>EZH2</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> but has escaped previous diagnosis because of a milder <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a>. Therefore, an apparently negative family history cannot be confirmed until appropriate evaluations have been performed.</div></li><li class="half_rhythm"><div>Note: If the parent is the individual in whom the <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> first occurred, s/he may have <a class="def" href="/books/n/gene/glossary/def-item/somatic-mosaicism/">somatic mosaicism</a> for the variant and may be mildly/minimally <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a>.</div></li></ul><p><b>Sibs of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a>.</b> The risk to the sibs of the proband depends on the genetic status of the proband's parents.</p><ul><li class="half_rhythm"><div>If testing reveals that a parent of the <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> has the <i>EZH2</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>, the risk to the sibs of inheriting the variant is 50%. The <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a> of an individual inheriting the <i>EZH2</i> pathogenic variant cannot be predicted.</div></li><li class="half_rhythm"><div>If the <i>EZH2</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> cannot be detected in the leukocyte DNA of either parent, the <a class="def" href="/books/n/gene/glossary/def-item/recurrence-risk/">recurrence risk</a> to sibs is estimated to be 1% because of the theoretic possibility of parental <a class="def" href="/books/n/gene/glossary/def-item/germline-mosaicism/">germline mosaicism</a> [<a class="bk_pop" href="#weaver.REF.rahbari.2016.126">Rahbari et al 2016</a>].</div></li></ul><p>If the parents have not been tested for the <i>EZH2</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> but are clinically unaffected, the risk to the sibs of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> is unclear because of the possibility of reduced <a class="def" href="/books/n/gene/glossary/def-item/penetrance/">penetrance</a> (or <a class="def" href="/books/n/gene/glossary/def-item/germline-mosaicism/">germline mosaicism</a>) in a parent.</p><p><b>Offspring of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a>.</b> Each child of an individual with <i>EZH2</i>-related overgrowth has a 50% chance of inheriting the <i>EZH2</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>.</p><p><b>Other family members.</b> The risk to other family members depends on the status of the <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a>'s parents: if a parent has an <i>EZH2</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>, his or her family members may be at risk.</p></div><div id="weaver.Related_Genetic_Counseling_Issues"><h3>Related Genetic Counseling Issues</h3><p><b>Considerations in families with an apparent <a class="def" href="/books/n/gene/glossary/def-item/de-novo/"><i>de novo</i></a> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>.</b> When neither parent of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> with an <a class="def" href="/books/n/gene/glossary/def-item/autosomal-dominant/">autosomal dominant</a> condition has the pathogenic variant identified in the proband or clinical evidence of the disorder, the pathogenic variant is likely <i>de novo</i>. However, non-medical explanations including <a class="def" href="/books/n/gene/glossary/def-item/alternate-paternity/">alternate paternity</a> or maternity (e.g., with assisted reproduction) and undisclosed adoption could also be explored.</p><p><b>Family planning</b></p><ul><li class="half_rhythm"><div>The optimal time for determination of genetic risk and discussion of the availability of prenatal testing is before pregnancy.</div></li><li class="half_rhythm"><div>It is appropriate to offer <a class="def" href="/books/n/gene/glossary/def-item/genetic-counseling/">genetic counseling</a> (including discussion of potential risks to offspring and reproductive options) to young adults who are <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> or at risk.</div></li></ul><p><b>DNA banking</b> is the storage of DNA (typically extracted from white blood cells) for possible future use. Because it is likely that testing methodology and our understanding of genes, allelic variants, and diseases will improve in the future, consideration should be given to banking DNA of <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals.</p></div><div id="weaver.Prenatal_Testing_and_Preimplantat"><h3>Prenatal Testing and Preimplantation Genetic Diagnosis</h3><p>Once the <i>EZH2</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> has been identified in an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> family member, prenatal testing for a pregnancy at increased risk and <a class="def" href="/books/n/gene/glossary/def-item/preimplantation-genetic-diagnosis/">preimplantation genetic diagnosis</a> are possible.</p><p>Differences in perspective may exist among medical professionals and within families regarding the use of prenatal testing, particularly if the testing is being considered for the purpose of pregnancy termination rather than early diagnosis. While most centers would consider decisions regarding prenatal testing to be the choice of the parents, discussion of these issues is appropriate.</p></div></div><div id="weaver.Resources"><h2 id="_weaver_Resources_">Resources</h2><p>
<i>GeneReviews staff has selected the following disease-specific and/or umbrella
support organizations and/or registries for the benefit of individuals with this disorder
and their families. GeneReviews is not responsible for the information provided by other
organizations. For information on selection criteria, click <a href="/books/n/gene/app4/">here</a>.</i></p><ul><li class="half_rhythm"><div><b>National Library of Medicine Genetics Home Reference</b></div><div><a href="http://ghr.nlm.nih.gov/condition/weaver-syndrome" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Weaver syndrome</a></div></li><li class="half_rhythm"><div><b>Child Growth Foundation</b></div><div>21 Malvern Drive</div><div>West Midlands B76 1PZ</div><div>United Kingdom</div><div><b>Phone:</b> 020 8995 0257</div><div><b>Email:</b> nfo@childgrowthfoundation.org</div><div><a href="http://www.childgrowthfoundation.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">www.childgrowthfoundation.org</a></div></li><li class="half_rhythm"><div><b>MAGIC Foundation</b></div><div>4200 Cantera Drive #106</div><div>Warrenville IL 60555</div><div><b>Phone:</b> 800-362-4423 (Toll-free Parent Help Line); 630-836-8200</div><div><b>Fax:</b> 630-836-8181</div><div><b>Email:</b> contactus@magicfoundation.org</div><div><a href="http://www.magicfoundation.org" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">www.magicfoundation.org</a></div></li></ul></div><div id="weaver.Molecular_Genetics"><h2 id="_weaver_Molecular_Genetics_">Molecular Genetics</h2><p><i>Information in the Molecular Genetics and OMIM tables may differ from that elsewhere in the GeneReview: tables may contain more recent information. &#x02014;</i>ED.</p><div id="weaver.molgen.TA" class="table"><h3><span class="label">Table A.</span></h3><div class="caption"><p>EZH2-Related Overgrowth: Genes and Databases</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK148820/table/weaver.molgen.TA/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__weaver.molgen.TA_lrgtbl__"><table class="no_bottom_margin"><tbody><tr><th id="hd_b_weaver.molgen.TA_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;">Gene</th><th id="hd_b_weaver.molgen.TA_1_1_1_2" rowspan="1" colspan="1" style="vertical-align:top;">Chromosome Locus</th><th id="hd_b_weaver.molgen.TA_1_1_1_3" rowspan="1" colspan="1" style="vertical-align:top;">Protein</th><th id="hd_b_weaver.molgen.TA_1_1_1_4" rowspan="1" colspan="1" style="vertical-align:top;">Locus-Specific Databases</th><th id="hd_b_weaver.molgen.TA_1_1_1_5" rowspan="1" colspan="1" style="vertical-align:top;">HGMD</th><th id="hd_b_weaver.molgen.TA_1_1_1_6" rowspan="1" colspan="1" style="vertical-align:top;">ClinVar</th></tr><tr><td headers="hd_b_weaver.molgen.TA_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;"><a href="/gene/2146" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=gene"><i>EZH2</i></a></td><td headers="hd_b_weaver.molgen.TA_1_1_1_2" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://www.ncbi.nlm.nih.gov/genome/gdv/?context=gene&#x00026;acc=2146" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">7q36<wbr style="display:inline-block"></wbr>​.1</a></td><td headers="hd_b_weaver.molgen.TA_1_1_1_3" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.uniprot.org/uniprot/Q15910" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Histone-lysine N-methyltransferase EZH2</a></td><td headers="hd_b_weaver.molgen.TA_1_1_1_4" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://databases.lovd.nl/shared/genes/EZH2" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">EZH2 database</a></td><td headers="hd_b_weaver.molgen.TA_1_1_1_5" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.hgmd.cf.ac.uk/ac/gene.php?gene=EZH2" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">EZH2</a></td><td headers="hd_b_weaver.molgen.TA_1_1_1_6" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://www.ncbi.nlm.nih.gov/clinvar/?term=EZH2[gene]" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">EZH2</a></td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt></dt><dd><div id="weaver.TFA.1"><p class="no_margin">Data are compiled from the following standard references: <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> from
<a href="http://www.genenames.org/index.html" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">HGNC</a>;
<a class="def" href="/books/n/gene/glossary/def-item/chromosome/">chromosome</a> <a class="def" href="/books/n/gene/glossary/def-item/locus/">locus</a> from
<a href="http://www.omim.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">OMIM</a>;
protein from <a href="http://www.uniprot.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">UniProt</a>.
For a description of databases (Locus Specific, HGMD, ClinVar) to which links are provided, click
<a href="/books/n/gene/app1/">here</a>.</p></div></dd></dl></div></div></div><div id="weaver.molgen.TB" class="table"><h3><span class="label">Table B.</span></h3><div class="caption"><p>OMIM Entries for EZH2-Related Overgrowth (<a href="/omim/277590,601573" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">View All in OMIM</a>) </p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK148820/table/weaver.molgen.TB/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__weaver.molgen.TB_lrgtbl__"><table><tbody><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/277590" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">277590</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">WEAVER SYNDROME; WVS</td></tr><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/601573" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">601573</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">ENHANCER OF ZESTE, DROSOPHILA, HOMOLOG 2; EZH2</td></tr></tbody></table></div></div><p><b>Gene structure.</b> There are multiple alternative transcripts. The longest, <a href="/nuccore/NM_004456.4" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">NM_004456.4</a>, comprises 20 exons; the first <a class="def" href="/books/n/gene/glossary/def-item/exon/">exon</a> is noncoding. For a detailed summary of <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> and protein information, see <a href="/books/NBK148820/#weaver.molgen.TA">Table A</a>, <b>Gene</b>.</p><p><b>Pathogenic variants.</b> Factors to consider in the interpretation of sequence variants:</p><ul><li class="half_rhythm"><div>All <a class="def" href="/books/n/gene/glossary/def-item/de-novo/"><i>de novo</i></a> <a class="def" href="/books/n/gene/glossary/def-item/germline/">germline</a> <a class="def" href="/books/n/gene/glossary/def-item/missense/">missense</a> and truncating variants in a <a class="def" href="/books/n/gene/glossary/def-item/simplex/">simplex</a> case (i.e., a single occurrence in a family) of Weaver syndrome are likely to be pathogenic.</div></li><li class="half_rhythm"><div>Inherited <a class="def" href="/books/n/gene/glossary/def-item/missense/">missense</a> and truncating variants that segregate with the overgrowth <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a> are likely to be pathogenic.</div></li><li class="half_rhythm"><div>If parental samples are not available, <a class="def" href="/books/n/gene/glossary/def-item/missense/">missense</a> and truncating variants should be interpreted with caution. Based on a small number of cases, current data (in which distribution of <i>EZH2</i> variants in cases vs controls, conservation of the SET <a class="def" href="/books/n/gene/glossary/def-item/domain/">domain</a> [see <b>Normal <a class="def" href="/books/n/gene/glossary/def-item/gene-product/">gene product</a></b>] residues, and critical function of the SET domain in mediating histone methyltransferase activity were analyzed) suggest that SET domain missense variants are likely pathogenic. In addition, the few truncating variants that have been identified are all located in the final <a class="def" href="/books/n/gene/glossary/def-item/exon/">exon</a> after the SET domain, although further studies are required to clarify the mechanism by which these variants cause overgrowth.</div></li></ul><div id="weaver.T.ezh2_pathogenic_variants_discus" class="table"><h3><span class="label">Table 6. </span></h3><div class="caption"><p><i>EZH2</i> Pathogenic Variants Discussed in This <i>GeneReview</i></p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK148820/table/weaver.T.ezh2_pathogenic_variants_discus/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__weaver.T.ezh2_pathogenic_variants_discus_lrgtbl__"><table class="no_bottom_margin"><thead><tr><th id="hd_h_weaver.T.ezh2_pathogenic_variants_discus_1_1_1_1" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">DNA Nucleotide Change</th><th id="hd_h_weaver.T.ezh2_pathogenic_variants_discus_1_1_1_2" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Predicted Protein Change</th><th id="hd_h_weaver.T.ezh2_pathogenic_variants_discus_1_1_1_3" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Reference Sequences</th></tr></thead><tbody><tr><td headers="hd_h_weaver.T.ezh2_pathogenic_variants_discus_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.395C&#x0003e;T</td><td headers="hd_h_weaver.T.ezh2_pathogenic_variants_discus_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Pro132Leu</td><td headers="hd_h_weaver.T.ezh2_pathogenic_variants_discus_1_1_1_3" rowspan="4" colspan="1" style="text-align:left;vertical-align:middle;"><a href="/nuccore/NM_004456.4" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">NM_004456<wbr style="display:inline-block"></wbr>​.4</a><br /><a href="/protein/NP_004447.2" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">NP_004447<wbr style="display:inline-block"></wbr>​.2</a></td></tr><tr><td headers="hd_h_weaver.T.ezh2_pathogenic_variants_discus_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.458A&#x0003e;G</td><td headers="hd_h_weaver.T.ezh2_pathogenic_variants_discus_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Tyr153Cys</td></tr><tr><td headers="hd_h_weaver.T.ezh2_pathogenic_variants_discus_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.2044G&#x0003e;A</td><td headers="hd_h_weaver.T.ezh2_pathogenic_variants_discus_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Ala682Thr</td></tr><tr><td headers="hd_h_weaver.T.ezh2_pathogenic_variants_discus_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.2233G&#x0003e;A</td><td headers="hd_h_weaver.T.ezh2_pathogenic_variants_discus_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Glu745Lys</td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt></dt><dd><div><p class="no_margin">Variants listed in the table have been provided by the authors. <i>GeneReviews</i> staff have not independently verified the classification of variants.</p></div></dd><dt></dt><dd><div><p class="no_margin"><i>GeneReviews</i> follows the standard naming conventions of the Human Genome Variation Society (<a href="http://varnomen.hgvs.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">varnomen<wbr style="display:inline-block"></wbr>​.hgvs.org</a>). See <a href="/books/n/gene/app3/">Quick Reference</a> for an explanation of nomenclature.</p></div></dd></dl></div></div></div><p><b>Normal <a class="def" href="/books/n/gene/glossary/def-item/gene-product/">gene product</a>.</b> EZH2 (<a href="/protein/NP_004447.2" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">NP_004447.2</a>), encoded by the longest transcript, is a 751-amino acid histone methyltransferase with a critical SET (su(var)3-9, enhancer of zeste, trithorax) <a class="def" href="/books/n/gene/glossary/def-item/domain/">domain</a>, a pre-SET CXC domain, and two additional SANT (Sw13, Ada2, N-cor TFIIIB) domains [<a class="bk_pop" href="#weaver.REF.wu.2013.e83737">Wu et al 2013</a>]. In combination with SUZ12 and EED (to form the polycomb repressor complex 2 [PCR2]), EZH2 acts to repress transcription through the <a class="def" href="/books/n/gene/glossary/def-item/methylation/">methylation</a> of lysine residue 27 of histone 3, a function catalyzed by the SET domain [<a class="bk_pop" href="#weaver.REF.cao.2002.1039">Cao et al 2002</a>].</p><p><b>Abnormal <a class="def" href="/books/n/gene/glossary/def-item/gene-product/">gene product</a>.</b> The protein alterations and the mechanism by which <i>EZH2</i> <a class="def" href="/books/n/gene/glossary/def-item/missense/">missense</a> and truncating variants cause Weaver syndrome are currently unknown. It is, however, noteworthy that pathogenic missense variants are the primary mutational mechanism; the few pathogenic truncating variants identified to date target the final <a class="def" href="/books/n/gene/glossary/def-item/exon/">exon</a> and thus are likely to escape <a class="def" href="/books/n/gene/glossary/def-item/nonsense-variant/">nonsense</a>-mediated RNA decay. Current evidence suggests that Weaver syndrome may be caused by impaired histone methyltransferase function [<a class="bk_pop" href="#weaver.REF.cohen.2016.301">Cohen et al 2016</a>, <a class="bk_pop" href="#weaver.REF.lui.2018.1470">Lui et al 2018</a>].</p><div id="weaver.Cancer_and_Benign_Tumors"><h3>Cancer and Benign Tumors</h3><p>Somatic activating and <a class="def" href="/books/n/gene/glossary/def-item/inactivating/">inactivating</a> mono- and <a class="def" href="/books/n/gene/glossary/def-item/biallelic/">biallelic</a> <i>EZH2</i> pathogenic variants have been identified in various hematopoietic malignancies. Of particular note, a recurrent activating <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> targeting the Tyr646 residue has been identified in lymphomas, particularly large B-cell lymphomas and follicular lymphomas; inactivating pathogenic variants throughout the <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> are identified in myelodysplastic and myeloproliferative neoplasms with a poor prognosis [<a class="bk_pop" href="#weaver.REF.morin.2010.181">Morin et al 2010</a>, <a class="bk_pop" href="#weaver.REF.sneeringer.2010.20980">Sneeringer et al 2010</a>, <a class="bk_pop" href="#weaver.REF.chase.2011.2613">Chase &#x00026; Cross 2011</a>].</p><p>Despite the association between somatic <a class="def" href="/books/n/gene/glossary/def-item/inactivating/">inactivating</a> <i>EZH2</i> pathogenic variants and older-onset, chronic myeloproliferative/dysplastic syndromes, these malignancies do not appear to occur at increased frequencies in individuals with <i>EZH2-</i>related overgrowth. Possible explanations for this finding:</p><ul><li class="half_rhythm"><div>Myeloproliferative/dysplastic syndromes usually occur at ages older than the age of most individuals currently identified with a <a class="def" href="/books/n/gene/glossary/def-item/germline/">germline</a> (constitutional) <i>EZH2</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>.</div></li><li class="half_rhythm"><div>The mechanisms by which <i>EZH2</i> somatic pathogenic variants cause malignancy and <i>EZH2</i> <a class="def" href="/books/n/gene/glossary/def-item/germline/">germline</a> pathogenic variants cause overgrowth differ.</div></li><li class="half_rhythm"><div>Relatively few individuals with <i>EZH2</i> <a class="def" href="/books/n/gene/glossary/def-item/germline/">germline</a> pathogenic variants have been identified to date.</div></li></ul></div></div><div id="weaver.References"><h2 id="_weaver_References_">References</h2><div id="weaver.Literature_Cited"><h3>Literature Cited</h3><ul class="simple-list"><li class="half_rhythm"><div class="bk_ref" id="weaver.REF.alsalem.2013.225">Al-Salem A, Alshammari MJ, Hassan H, Alazami AM, Alkuraya FS. Weaver syndrome and defective cortical development: a rare association. <span><span class="ref-journal">Am J Med Genet A. </span>2013;<span class="ref-vol">161A</span>:225–7.</span> [<a href="/pubmed/23239504" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 23239504</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="weaver.REF.cao.2002.1039">Cao R, Wang L, Wang H, Xia L, Erdjument-Bromage H, Tempst P, Jones RS, Zhang Y. Role of histone H3 lysine 27 methylation in Polycomb-group silencing. <span><span class="ref-journal">Science. </span>2002;<span class="ref-vol">298</span>:1039–43.</span> [<a href="/pubmed/12351676" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 12351676</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="weaver.REF.chase.2011.2613">Chase A, Cross NC. Aberrations of EZH2 in cancer. <span><span class="ref-journal">Clin Cancer Res. </span>2011;<span class="ref-vol">17</span>:2613–8.</span> [<a href="/pubmed/21367748" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 21367748</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="weaver.REF.choufani.2010.343">Choufani S, Shuman C, Weksberg R. Beckwith-Wiedemann syndrome. <span><span class="ref-journal">Am J Med Genet C Semin Med Genet. </span>2010;<span class="ref-vol">154C</span>:343–54.</span> [<a href="/pubmed/20803657" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 20803657</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="weaver.REF.cohen.2016.301">Cohen AS, Yap DB, Lewis ME, Chijiwa C, Ramos-Arroyo MA, Tkachenko N, Milano V, Fradin M, McKinnon ML, Townsend KN, Xu J, Van Allen MI, Ross CJ, Dobyns WB, Weaver DD, Gibson WT. Weaver syndrome-associated EZH2 protein variants show impaired histone methyltransferase function in vitro. <span><span class="ref-journal">Hum Mutat. </span>2016;<span class="ref-vol">37</span>:301–7.</span> [<a href="/pmc/articles/PMC4832389/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC4832389</span></a>] [<a href="/pubmed/26694085" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 26694085</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="weaver.REF.cottereau.2013.92">Cottereau E, Mortemousque I, Moizard MP, B&#x000fc;rglen L, Lacombe D, Gilbert-Dussardier B, Sigaudy S, Boute O, David A, Faivre L, Amiel J, Robertson R, Viana Ramos F, Bieth E, Odent S, Demeer B, Mathieu M, Gaillard D, Van Maldergem L, Baujat G, Maystadt I, H&#x000e9;ron D, Verloes A, Philip N, Cormier-Daire V, Frout&#x000e9; MF, Pinson L, Blanchet P, Sarda P, Willems M, Jacquinet A, Ratbi I, Van Den Ende J, Lackmy-Port Lis M, Goldenberg A, Bonneau D, Rossignol S, Toutain A. Phenotypic spectrum of Simpson-Golabi-Behmel syndrome in a series of 42 cases with a mutation in GPC3 and review of the literature. <span><span class="ref-journal">Am J Med Genet C Semin Med Genet. </span>2013;<span class="ref-vol">163C</span>:92–105.</span> [<a href="/pubmed/23606591" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 23606591</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="weaver.REF.douglas.2003.132">Douglas J, Hanks S, Temple IK, Davies S, Murray A, Upadhyaya M, Tomkins S, Hughes HE, Cole TR, Rahman N. NSD1 mutations are the major cause of Sotos syndrome and occur in some cases of Weaver syndrome but are rare in other overgrowth phenotypes. <span><span class="ref-journal">Am J Hum Genet. </span>2003;<span class="ref-vol">72</span>:132–43.</span> [<a href="/pmc/articles/PMC378618/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC378618</span></a>] [<a href="/pubmed/12464997" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 12464997</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="weaver.REF.gibson.2012.110">Gibson WT, Hood RL, Zhan SH, Bulman DE, Fejes AP, Moore R, Mungall AJ, Eydoux P, Babul-Hirji R, An J, Marra MA., FORGE Canada Consortium.  Chitayat D, Boycott KM, Weaver DD, Jones SJ. Mutations in EZH2 cause Weaver syndrome. <span><span class="ref-journal">Am J Hum Genet. </span>2012;<span class="ref-vol">90</span>:110–8.</span> [<a href="/pmc/articles/PMC3257956/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC3257956</span></a>] [<a href="/pubmed/22177091" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 22177091</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="weaver.REF.golabi.1984.345">Golabi M, Rosen L. A new X-linked mental retardation-overgrowth syndrome. <span><span class="ref-journal">Am J Med Genet. </span>1984;<span class="ref-vol">17</span>:345–58.</span> [<a href="/pubmed/6538755" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 6538755</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="weaver.REF.imagawa.2017.637">Imagawa E, Higashimoto K, Sakai Y, Numakura C, Okamoto N, Matsunaga S, Ryo A, Sato Y, Sanefuji M, Ihara K, Takada Y, Nishimura G, Saitsu H, Mizuguchi T, Miyatake S, Nakashima M, Miyake N, Soejima H, Matsumoto N. Mutations in genes encoding polycomb repressive complex 2 subunits cause Weaver syndrome. <span><span class="ref-journal">Hum Mutat. </span>2017;<span class="ref-vol">38</span>:637–48.</span> [<a href="/pubmed/28229514" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 28229514</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="weaver.REF.klaassens.2015.610">Klaassens M, Morrogh D, Rosser EM, Jaffer F, Vreeburg M, Bok LA, Segboer T, van Belzen M, Quinlivan RM, Kumar A, Hurst JA, Scott RH. Malan syndrome: Sotos-like overgrowth with de novo NFIX sequence variants and deletions in six new patients and a review of the literature. <span><span class="ref-journal">Eur J Hum Genet. </span>2015;<span class="ref-vol">23</span>:610–5.</span> [<a href="/pmc/articles/PMC4402637/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC4402637</span></a>] [<a href="/pubmed/25118028" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 25118028</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="weaver.REF.lui.2018.1470">Lui JC, Barnes KM, Dong L, Yue S, Graber E, Rapaport R, Dauber A, Nilsson O, Baron J. Ezh2 mutations found in the Weaver overgrowth syndrome cause a partial loss of H3K27 histone methyltransferase activity. <span><span class="ref-journal">J Clin Endocrinol Metab. </span>2018;<span class="ref-vol">103</span>:1470–8.</span> [<a href="/pmc/articles/PMC6276576/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC6276576</span></a>] [<a href="/pubmed/29244146" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 29244146</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="weaver.REF.malan.2010.189">Malan V, Rajan D, Thomas S, Shaw AC, Louis Dit Picard H, Layet V, Till M, van Haeringen A, Mortier G, Nampoothiri S, Puseljic S, Legeai-Mallet L, Carter NP, Vekemans M, Munnich A, Hennekam RC, Colleaux L, Cormier-Daire V. Distinct effects of allelic NFIX mutations on nonsense-mediated mRNA decay engender either a Sotos-like or a Marshall-Smith syndrome. <span><span class="ref-journal">Am J Hum Genet. </span>2010;<span class="ref-vol">87</span>:189–98.</span> [<a href="/pmc/articles/PMC2917711/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC2917711</span></a>] [<a href="/pubmed/20673863" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 20673863</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="weaver.REF.morin.2010.181">Morin RD, Johnson NA, Severson TM, Mungall AJ, An J, Goya R, Paul JE, Boyle M, Woolcock BW, Kuchenbauer F, Yap D, Humphries RK, Griffith OL, Shah S, Zhu H, Kimbara M, Shashkin P, Charlot JF, Tcherpakov M, Corbett R, Tam A, Varhol R, Smailus D, Moksa M, Zhao Y, Delaney A, Qian H, Birol I, Schein J, Moore R, Holt R, Horsman DE, Connors JM, Jones S, Aparicio S, Hirst M, Gascoyne RD, Marra MA. Somatic mutations altering EZH2 (Tyr641) in follicular and diffuse large B-cell lymphomas of germinal-center origin. <span><span class="ref-journal">Nat Genet. </span>2010;<span class="ref-vol">42</span>:181–5.</span> [<a href="/pmc/articles/PMC2850970/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC2850970</span></a>] [<a href="/pubmed/20081860" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 20081860</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="weaver.REF.priolo.2018.1226">Priolo M, Schanze D, Tatton-Brown K, Mulder PA, Tenorio J, Kooblall K, Acero IH, Alkuraya FS, Arias P, Bernardini L, Bijlsma EK, Cole T, Coubes C, Dapia I, Davies S, Di Donato N, Elcioglu NH, Fahrner JA, Foster A, Gonz&#x000e1;lez NG, Huber I, Iascone M, Kaiser AS, Kamath A, Liebelt J, Lynch SA, Maas SM, Mamm&#x000ec; C, Mathijssen IB, McKee S, Menke LA, Mirzaa GM, Montgomery T, Neubauer D, Neumann TE, Pintomalli L, Pisanti MA, Plomp AS, Price S, Salter C, Santos-Simarro F, Sarda P, Segovia M, Shaw-Smith C, Smithson S, Suri M, Valdez RM, Van Haeringen A, Van Hagen JM, Zollino M, Lapunzina P, Thakker RV, Zenker M, Hennekam RC. Further delineation of Malan syndrome. <span><span class="ref-journal">Hum Mutat. </span>2018;<span class="ref-vol">39</span>:1226–37.</span> [<a href="/pmc/articles/PMC6175110/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC6175110</span></a>] [<a href="/pubmed/29897170" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 29897170</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="weaver.REF.rahbari.2016.126">Rahbari R, Wuster A, Lindsay SJ, Hardwick RJ, Alexandrov LB, Turki SA, Dominiczak A, Morris A, Porteous D, Smith B, Stratton MR. UK10K Consortium, Hurles ME. Timing, rates and spectra of human germline mutation. <span><span class="ref-journal">Nat Genet. </span>2016;<span class="ref-vol">48</span>:126–33.</span> [<a href="/pmc/articles/PMC4731925/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC4731925</span></a>] [<a href="/pubmed/26656846" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 26656846</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="weaver.REF.schanze.2014.1092">Schanze D, Neubauer D, Cormier-Daire V, Delrue MA, Dieux-Coeslier A, Hasegawa T, Holmberg EE, Koenig R, Krueger G, Schanze I, Seemanova E, Shaw AC, Vogt J, Volleth M, Reis A, Meinecke P, Hennekam RC, Zenker M. Deletions in the 3' part of the NFIX gene including a recurrent Alu-mediated deletion of exon 6 and 7 account for previously unexplained cases of Marshall-Smith syndrome. <span><span class="ref-journal">Hum Mutat. </span>2014;<span class="ref-vol">35</span>:1092–100.</span> [<a href="/pubmed/24924640" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 24924640</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="weaver.REF.sneeringer.2010.20980">Sneeringer CJ, Scott MP, Kuntz KW, Knutson SK, Pollock RM, Richon VM, Copeland RA. Coordinated activities of wild-type plus mutant EZH2 drive tumor-associated hypertrimethylation of lysine 27 on histone H3 (H3K27) in human B-cell lymphomas. <span><span class="ref-journal">Proc Natl Acad Sci U S A. </span>2010;<span class="ref-vol">107</span>:20980–5.</span> [<a href="/pmc/articles/PMC3000297/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC3000297</span></a>] [<a href="/pubmed/21078963" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 21078963</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="weaver.REF.suri.2017.2731">Suri T, Dixit A. The phenotype of EZH2 haploinsufficiency-1.2-Mb deletion at 7q36.1 in a child with tall stature and intellectual disability. <span><span class="ref-journal">Am J Med Genet A. </span>2017;<span class="ref-vol">173</span>:2731–5.</span> [<a href="/pubmed/28696078" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 28696078</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="weaver.REF.tattonbrown.2005.193">Tatton-Brown K, Douglas J, Coleman K, Baujat G, Cole TR, Das S, Horn D, Hughes HE, Temple IK, Faravelli F, Waggoner D, Turkmen S, Cormier-Daire V, Irrthum A, Rahman N. Genotype-phenotype associations in Sotos syndrome: an analysis of 266 individuals with NSD1 aberrations. <span><span class="ref-journal">Am J Hum Genet. </span>2005;<span class="ref-vol">77</span>:193–204.</span> [<a href="/pmc/articles/PMC1224542/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC1224542</span></a>] [<a href="/pubmed/15942875" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 15942875</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="weaver.REF.tattonbrown.2011.1127">Tatton-Brown K, Hanks S, Ruark E, Zachariou A, Duarte Sdel V, Ramsay E, Snape K, Murray A, Perdeaux ER, Seal S, Loveday C, Banka S, Clericuzio C, Flinter F, Magee A, McConnell V, Patton M, Raith W, Rankin J, Splitt M, Strenger V, Taylor C, Wheeler P, Temple KI, Cole T, Douglas J, Rahman N. Germline mutations in the oncogene EZH2 cause Weaver syndrome and increased human height. <span><span class="ref-journal">Oncotarget. </span>2011;<span class="ref-vol">2</span>:1127–33.</span> [<a href="/pmc/articles/PMC3282071/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC3282071</span></a>] [<a href="/pubmed/22190405" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 22190405</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="weaver.REF.tattonbrown.2013.2972">Tatton-Brown K, Murray A, Hanks S, Douglas J, Armstrong R, Banka S, Bird LM, Clericuzio CL, Cormier-Daire V, Cushing T, Flinter F, Jacquemont ML, Joss S, Kinning E, Lynch SA, Magee A, McConnell V, Medeira A, Ozono K, Patton M, Rankin J, Shears D, Simon M, Splitt M, Strenger V, Stuurman K, Taylor C, Titheradge H, Van Maldergem L, Temple IK, Cole T, Seal S., Childhood Overgrowth Consortium.  Rahman N. Weaver syndrome and EZH2 mutations: clarifying the clinical phenotype. <span><span class="ref-journal">Am J Med Genet A. </span>2013;<span class="ref-vol">161A</span>:2972–80.</span> [<a href="/pubmed/24214728" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 24214728</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="weaver.REF.tattonbrown.2014.385">Tatton-Brown K, Seal S, Ruark E, Harmer J, Ramsay E, Del Vecchio Duarte S, Zachariou A, Hanks S, O'Brien E, Aksglaede L, Baralle D, Dabir T, Gener B, Goudie D, Homfray T, Kumar A, Pilz DT, Selicorni A, Temple IK, Van Maldergem L, Yachelevich N., Childhood Overgrowth Consortium.  van Montfort R, Rahman N. Mutations in the DNA methyltransferase gene DNMT3A cause an overgrowth syndrome with intellectual disability. <span><span class="ref-journal">Nat Genet. </span>2014;<span class="ref-vol">46</span>:385–8.</span> [<a href="/pmc/articles/PMC3981653/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC3981653</span></a>] [<a href="/pubmed/24614070" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 24614070</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="weaver.REF.tattonbrown.2018.46">Tatton-Brown K, Zachariou A, Loveday C, Renwick A, Mahamdallie S, Aksglaede L, Baralle D, Barge-Schaapveld D, Blyth M, Bouma M, Breckpot J, Crabb B, Dabir T, Cormier-Daire V, Fauth C, Fisher R, Gener B, Goudie D, Homfray T, Hunter M, Jorgensen A, Kant SG, Kirally-Borri C, Koolen D, Kumar A, Labilloy A, Lees M, Marcelis C, Mercer C, Mignot C, Miller K, Neas K, Newbury-Ecob R, Pilz DT, Posmyk R, Prada C, Ramsey K, Randolph LM, Selicorni A, Shears D, Suri M, Temple IK, Turnpenny P, Val Maldergem L, Varghese V, Veenstra-Knol HE, Yachelevich N, Yates L, Rahman N, et al.  The Tatton-Brown-Rahman syndrome: a clinical study of 55 individuals with de novo constitutive <em>DNMT3A</em> variants. <span><span class="ref-journal">Wellcome Open Res. </span>2018;<span class="ref-vol">3</span>:46.</span> [<a href="/pmc/articles/PMC5964628/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC5964628</span></a>] [<a href="/pubmed/29900417" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 29900417</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="weaver.REF.usemann.2016.1274">Usemann J, Ernst T, Sch&#x000e4;fer V, Lehmberg K, Seeger K. EZH2 mutation in an adolescent with Weaver syndrome developing acute myeloid leukemia and secondary hemophagocytic lymphohistiocytosis. <span><span class="ref-journal">Am J Med Genet A. </span>2016;<span class="ref-vol">170A</span>:1274–7.</span> [<a href="/pubmed/26762561" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 26762561</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="weaver.REF.weaver.1974.547">Weaver DD, Graham CB, Thomas IT, Smith DW. A new overgrowth syndrome with accelerated skeletal maturation, unusual facies, and camptodactyly. <span><span class="ref-journal">J Pediatr. </span>1974;<span class="ref-vol">84</span>:547–52.</span> [<a href="/pubmed/4366187" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 4366187</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="weaver.REF.wu.2013.e83737">Wu H, Zeng H, Dong A, Li F, He H, Senisterra G, Seitova A, Duan S, Brown PJ, Vedadi M, Arrowsmith CH, Schapira M. Structure of the catalytic domain of EZH2 reveals conformational plasticity in cofactor and substrate binding sites and explains oncogenic mutations. <span><span class="ref-journal">PLoS One. </span>2013;<span class="ref-vol">8</span>:e83737.</span> [<a href="/pmc/articles/PMC3868588/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC3868588</span></a>] [<a href="/pubmed/24367611" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 24367611</span></a>]</div></li></ul></div></div><div id="weaver.Chapter_Notes"><h2 id="_weaver_Chapter_Notes_">Chapter Notes</h2><div id="weaver.Revision_History"><h3>Revision History</h3><ul><li class="half_rhythm"><div>2 August 2018 (bp) Comprehensive update posted live</div></li><li class="half_rhythm"><div>6 August 2015 (me) Comprehensive update posted live</div></li><li class="half_rhythm"><div>18 July 2013 (me) Review posted live</div></li><li class="half_rhythm"><div>23 January 2013 (ktb) Original submission</div></li></ul></div></div><div style="display:none"><div id="figbwsF1"><img alt="Image bws-Image001" src-large="/books/n/gene/bws/bin/bws-Image001.jpg" /></div></div><div id="bk_toc_contnr"></div></div></div>
            <div class="post-content"><div><div class="half_rhythm"><a href="/books/about/copyright/">Copyright</a> © 1993-2019, University of Washington, Seattle. GeneReviews is
a registered trademark of the University of Washington, Seattle. All rights
reserved.<p class="small">GeneReviews® chapters are owned by the University of Washington. Permission is
hereby granted to reproduce, distribute, and translate copies of content materials for
noncommercial research purposes only, provided that (i) credit for source (<a href="http://www.genereviews.org/" ref="pagearea=meta&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">http://www.genereviews.org/</a>) and copyright (© 1993-2019 University of
Washington) are included with each copy; (ii) a link to the original material is provided
whenever the material is published elsewhere on the Web; and (iii) reproducers,
distributors, and/or translators comply with the <a href="/books/n/gene/GRcopyright_permiss/">GeneReviews® Copyright Notice and Usage
Disclaimer</a>. No further modifications are allowed. For clarity, excerpts
of GeneReviews chapters for use in lab reports and clinic notes are a permitted
use.</p><p class="small">For more information, see the <a href="/books/n/gene/GRcopyright_permiss/">GeneReviews® Copyright Notice and Usage
Disclaimer</a>.</p><p class="small">For questions regarding permissions or whether a specified use is allowed,
contact: <a href="mailto:dev@null" data-email="ude.wu@tssamda" class="oemail">ude.wu@tssamda</a>.</p></div><div class="small"><span class="label">Bookshelf ID: NBK148820</span><span class="label">PMID: <a href="/pubmed/23865096" title="PubMed record of this page" ref="pagearea=meta&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">23865096</a></span></div><div style="margin-top:2em" class="bk_noprnt"><a class="bk_cntns" href="/books/n/gene/">GeneReviews by Title</a><div class="pagination bk_noprnt"><a class="active page_link prev" href="/books/n/gene/exosc3-pc-hypo-p/" title="Previous page in this title">&lt; Prev</a><a class="active page_link next" href="/books/n/gene/alzheimer-early/" title="Next page in this title">Next &gt;</a></div></div></div></div>
            
        </div>

        <!-- Custom content below content -->
        <div class="col4">
            
        </div>
        
        
        <!-- Book content -->
        
        <!-- Custom contetnt below bottom nav -->
        <div class="col5">
            
        </div>
    </div>

    <div id="rightcolumn" class="four_col col last">
        <!-- Custom content above discovery portlets -->
        <div class="col6">
            <div id="ncbi_share_book"><a href="#" class="ncbi_share" data-ncbi_share_config="popup:false,shorten:true" ref="id=NBK148820&amp;db=books">Share</a></div>

        </div>
        <div xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Views</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="PDF_download" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="/books/NBK148820/?report=reader">PubReader</a></li><li><a href="/books/NBK148820/?report=printable">Print View</a></li><li><a data-jig="ncbidialog" href="#_ncbi_dlg_citbx_NBK148820" data-jigconfig="width:400,modal:true">Cite this Page</a><div id="_ncbi_dlg_citbx_NBK148820" style="display:none" title="Cite this Page"><div class="bk_tt">Tatton-Brown K, Rahman N. EZH2-Related Overgrowth. 2013 Jul 18 [Updated 2018 Aug 2]. In: Adam MP, Ardinger HH, Pagon RA, et al., editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2019. <span class="bk_cite_avail"></span></div></div></li><li><a href="/books/NBK148820/pdf/Bookshelf_NBK148820.pdf">PDF version of this page</a> (538K)</li><li><a href="#" class="toggle-glossary-link" title="Enable/disable links to the glossary">Disable Glossary Links</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>In this GeneReview</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="page-toc" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="#weaver.Summary" ref="log$=inpage&amp;link_id=inpage">Summary</a></li><li><a href="#weaver.GeneReview_Scope" ref="log$=inpage&amp;link_id=inpage"><i>GeneReview</i> Scope</a></li><li><a href="#weaver.Diagnosis" ref="log$=inpage&amp;link_id=inpage">Diagnosis</a></li><li><a href="#weaver.Clinical_Characteristics" ref="log$=inpage&amp;link_id=inpage">Clinical Characteristics</a></li><li><a href="#weaver.Genetically_Related_Allelic_Disor" ref="log$=inpage&amp;link_id=inpage">Genetically Related (Allelic) Disorders</a></li><li><a href="#weaver.Differential_Diagnosis" ref="log$=inpage&amp;link_id=inpage">Differential Diagnosis</a></li><li><a href="#weaver.Management" ref="log$=inpage&amp;link_id=inpage">Management</a></li><li><a href="#weaver.Genetic_Counseling" ref="log$=inpage&amp;link_id=inpage">Genetic Counseling</a></li><li><a href="#weaver.Resources" ref="log$=inpage&amp;link_id=inpage">Resources</a></li><li><a href="#weaver.Molecular_Genetics" ref="log$=inpage&amp;link_id=inpage">Molecular Genetics</a></li><li><a href="#weaver.References" ref="log$=inpage&amp;link_id=inpage">References</a></li><li><a href="#weaver.Chapter_Notes" ref="log$=inpage&amp;link_id=inpage">Chapter Notes</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>GeneReviews Links</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="source-links" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="/books/n/gene/advanced/"><i>GeneReviews</i> Advanced Search</a></li><li><a href="/books/n/gene/glossary/"><i>GeneReviews</i> Glossary</a></li><li><a href="/books/n/gene/resource_mats/">Resource Materials</a> <span class="bk_hlight1">NEW FEATURE</span></li><li><a href="/books/n/gene/updates/">New in <i>GeneReviews</i></a></li><li><a href="/books/n/gene/authors/">Author List</a></li><li><a href="/books/n/gene/prospective_authors/">For Current/Prospective Authors</a></li><li><a href="/books/n/gene/GRpersonnel/"><i>GeneReviews</i> Personnel</a></li><li><a href="/books/n/gene/howto_linkin/">Download/Link to <i>GeneReviews</i></a></li><li><a href="/books/n/gene/contact_us/">Contact Us</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Tests in GTR by Gene</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="document-links" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="https://www.ncbi.nlm.nih.gov/gtr/tests/?term=2146[geneid]" ref="pagearea=document-links&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri&amp;link_id=tests_in_gtr_by_gene">EZH2</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Variations in ClinVar</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="document-links" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="https://www.ncbi.nlm.nih.gov/clinvar/?term=NBK148820+AND+genereviews[submitter]" ref="pagearea=document-links&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Variations from this GeneReview in ClinVar</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Related information</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="discovery_db_links" id="Shutter"></a></div><div class="portlet_content"><ul><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=omim&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_omim&amp;IdsFromResult=3043720" ref="log$=recordlinks">OMIM</a><div class="brieflinkpop offscreen_noflow">Related OMIM records</div></li><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=pmc&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_pmc_refs&amp;IdsFromResult=3043720" ref="log$=recordlinks">PMC</a><div class="brieflinkpop offscreen_noflow">PubMed Central citations</div></li><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=pubmed&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_pubmed_refs&amp;IdsFromResult=3043720" ref="log$=recordlinks">PubMed</a><div class="brieflinkpop offscreen_noflow">Links to PubMed</div></li><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=gene&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_gene&amp;IdsFromResult=3043720" ref="log$=recordlinks">Gene</a><div class="brieflinkpop offscreen_noflow">Locus Links</div></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Similar articles in PubMed</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="PBooksDiscovery_RA" id="Shutter"></a></div><div class="portlet_content"><ul><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/20301680" ref="ordinalpos=1&amp;linkpos=1&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Costello Syndrome</a><span class="source">[GeneReviews<sup>®</sup>. 1993]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Costello Syndrome<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Gripp KW, Rauen KA. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">GeneReviews®. 1993</em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/20301510" ref="ordinalpos=1&amp;linkpos=2&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Marfan Syndrome</a><span class="source">[GeneReviews<sup>®</sup>. 1993]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Marfan Syndrome<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Dietz H. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">GeneReviews®. 1993</em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/24214728" ref="ordinalpos=1&amp;linkpos=3&amp;log$=relatedarticles&amp;logdbfrom=pubmed">Weaver syndrome and EZH2 mutations: Clarifying the clinical phenotype.</a><span class="source">[Am J Med Genet A. 2013]</span><div class="brieflinkpop offscreen_noflow">Weaver syndrome and EZH2 mutations: Clarifying the clinical phenotype.<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Tatton-Brown K, Murray A, Hanks S, Douglas J, Armstrong R, Banka S, Bird LM, Clericuzio CL, Cormier-Daire V, Cushing T, et al. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">Am J Med Genet A. 2013 Dec; 161A(12):2972-80. Epub 2013 Nov 8.</em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/23946963" ref="ordinalpos=1&amp;linkpos=4&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> <i xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">PIK3CA</i>-Related Segmental Overgrowth</a><span class="source">[GeneReviews<sup>®</sup>. 1993]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> <i xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">PIK3CA</i>-Related Segmental Overgrowth<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Mirzaa G, Conway R, Graham JM Jr, Dobyns WB. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">GeneReviews®. 1993</em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/20301312" ref="ordinalpos=1&amp;linkpos=5&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Loeys-Dietz Syndrome</a><span class="source">[GeneReviews<sup>®</sup>. 1993]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Loeys-Dietz Syndrome<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Loeys BL, Dietz HC. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">GeneReviews®. 1993</em></div></div></li></ul><a class="seemore" href="/sites/entrez?db=pubmed&amp;cmd=link&amp;linkname=pubmed_pubmed_reviews&amp;uid=23865096" ref="ordinalpos=1&amp;log$=relatedreviews_seeall&amp;logdbfrom=pubmed">See reviews...</a><a class="seemore" href="/sites/entrez?db=pubmed&amp;cmd=link&amp;linkname=pubmed_pubmed&amp;uid=23865096" ref="ordinalpos=1&amp;log$=relatedarticles_seeall&amp;logdbfrom=pubmed">See all...</a></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Recent Activity</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="recent_activity" id="Shutter"></a></div><div class="portlet_content"><div xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" id="HTDisplay" class=""><div class="action"><a href="javascript:historyDisplayState('ClearHT')">Clear</a><a href="javascript:historyDisplayState('HTOff')" class="HTOn">Turn Off</a><a href="javascript:historyDisplayState('HTOn')" class="HTOff">Turn On</a></div><ul id="activity"><li class="ra_rcd ralinkpopper two_line"><a class="htb ralinkpopperctrl" ref="log$=activity&amp;linkpos=1" href="/portal/utils/pageresolver.fcgi?recordid=5e040f0edde08911696f41ab">EZH2-Related Overgrowth - GeneReviews®</a><div class="ralinkpop offscreen_noflow">EZH2-Related Overgrowth - GeneReviews®<div class="brieflinkpopdesc"></div></div><div class="tertiary"></div></li></ul><p class="HTOn">Your browsing activity is empty.</p><p class="HTOff">Activity recording is turned off.</p><p id="turnOn" class="HTOff"><a href="javascript:historyDisplayState('HTOn')">Turn recording back on</a></p><a class="seemore" href="/sites/myncbi/recentactivity">See more...</a></div></div></div>
        
        <!-- Custom content below discovery portlets -->
        <div class="col7">
            
        </div>
    </div>
</div>

<!-- Custom content after all -->
<div class="col8">
    
</div>
<div class="col9">
    
</div>

<script type="text/javascript" src="/corehtml/pmc/js/jquery.scrollTo-1.4.2.js"></script>
<script type="text/javascript">
    (function($){
        $('.skiplink').each(function(i, item){
            var href = $($(item).attr('href'));
            href.attr('tabindex', '-1').addClass('skiptarget'); // ensure the target can receive focus
            $(item).on('click', function(event){
                event.preventDefault();
                $.scrollTo(href, 0, {
                    onAfter: function(){
                        href.focus();
                    }
                });
            });
        });
    })(jQuery);
</script>
                        </div>
                        <div class="bottom">
                            
                            <div id="NCBIFooter_dynamic">
    <a id="help-desk-link" class="help_desk" href="" target="_blank">Support Center</a>
    <a id="help-desk-link" class="help_desk" href="https://support.ncbi.nlm.nih.gov/ics/support/KBList.asp?Time=2019-12-25T20:38:22-05:00&amp;Snapshot=%2Fprojects%2Fbooks%2FPBooks@5.22&amp;Host=portal105&amp;ncbi_phid=CE8C0187E0405DF10000000003D10142&amp;ncbi_session=CE8C0187E040F0E1_0977SID&amp;from=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fbooks%2FNBK148820%2F&amp;Db=pmc&amp;folderID=134&amp;Ncbi_App=bookshelf&amp;Page=literature&amp;style=classic&amp;deptID=28049" target="_blank">Support Center</a>
    
</div>

                            <div class="footer" id="footer">
    
    <div class="subfooter"> </div><script type="text/javascript" src="/portal/portal3rc.fcgi/static/js/preloaderWidget.js"> </script>
    <div id="external-disclaimer" class="offscreen_noflow">
        External link. Please review our <a href="https://www.nlm.nih.gov/privacy.html">privacy policy</a>.
    </div>    
    <div id="ncbifooter" class="contact_info">      
        <div id="footer-contents-right">
            <div id="nlm_thumb_logo">
                <a href="https://www.nlm.nih.gov" title="NLM">NLM</a>
            </div>
            <div id="nih_thumb_logo">
                <a href="https://www.nih.gov" title="NIH">NIH</a>
            </div>
            <div id="hhs_thumb_logo">
                <a href="https://www.hhs.gov" title="DHHS">DHHS</a>
            </div>
            <div id="usagov_thumb_logo">
                <a href="https://www.usa.gov" title="USA.gov">USA.gov</a>
            </div>         
        </div>
        
        <div id="footer-contents-left">
            <p class="address vcard">
                <span class="url">
                    <a class="fn url newdomain" href="https://www.ncbi.nlm.nih.gov">National Center for
                        Biotechnology Information</a>,
                </span> <span class="org url newdomain"><a href="https://www.nlm.nih.gov/">U.S. National Library of Medicine</a></span>
                <span class="adr">
                    <span class="street-address">8600 Rockville Pike</span>, <span class="locality">Bethesda</span>
                    <span class="region">MD</span>, <span class="postal-code">20894</span>
                    <span class="country-name">USA</span>
                </span>
            </p>
            
            <a href="/home/about/policies.shtml">Policies and Guidelines</a> | <a href="/home/about/contact.shtml">Contact</a>
        </div>
    </div>
    <script type="text/javascript" src="/portal/portal3rc.fcgi/rlib/js/InstrumentOmnitureBaseJS/InstrumentNCBIConfigJS/InstrumentNCBIBaseJS/InstrumentPageStarterJS.js?v=1"> </script>    
    <script type="text/javascript" src="/portal/portal3rc.fcgi/static/js/hfjs2.js"> </script>
</div>
                        </div>
                    </div>
                    <!--/.page-->
                </div>
                <!--/.wrap-->
            </div><!-- /.twelve_col -->
        </div>
        <!-- /.grid -->

        <span class="PAFAppResources"></span>
        
        <!-- BESelector tab -->
        
        
        
        <noscript><img alt="statistics" src="/stat?jsdisabled=true&amp;ncbi_db=books&amp;ncbi_pdid=book-part&amp;ncbi_acc=NBK148820&amp;ncbi_domain=gene&amp;ncbi_report=record&amp;ncbi_type=fulltext&amp;ncbi_objectid=&amp;ncbi_pcid=/NBK148820/&amp;ncbi_pagename=EZH2-Related Overgrowth - GeneReviews® - NCBI Bookshelf&amp;ncbi_bookparttype=chapter&amp;ncbi_app=bookshelf" /></noscript>
        
        
        <!-- usually for JS scripts at page bottom -->
        <!--<component id="PageFixtures" label="styles"></component>-->
    

<!-- CE8C0187E040F0E1_0977SID /projects/books/PBooks@5.22 portal105 v4.1.r585844 Mon, May 06 2019 02:53:16 -->

<script type="text/javascript" src="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/js/3879255/4121861/3501987/4008961/3893018/3821238/4062932/4123007/4087685/4076480/3921943/3400083/3426610.js" snapshot="books"></script></body>
</html>